{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["flavonoids", "inflammation", "inflammatory mediators", "metabolic disorders", "nuclear factor-\u03baB", "oxidative stress"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "31597283", "DateCompleted": {"Year": "2020", "Month": "02", "Day": "17"}, "DateRevised": {"Year": "2020", "Month": "02", "Day": "17"}, "Article": {"ArticleDate": [{"Year": "2019", "Month": "10", "Day": "08"}], "Language": ["eng"], "ELocationID": ["4957", "10.3390/ijms20194957"], "Journal": {"ISSN": "1422-0067", "JournalIssue": {"Volume": "20", "Issue": "19", "PubDate": {"Year": "2019", "Month": "Oct", "Day": "08"}}, "Title": "International journal of molecular sciences", "ISOAbbreviation": "Int J Mol Sci"}, "ArticleTitle": "Targeting Inflammation by Flavonoids: Novel Therapeutic Strategy for Metabolic Disorders.", "Abstract": {"AbstractText": ["A balanced metabolic profile is essential for normal human physiological activities. Disproportions in nutrition give rise to imbalances in metabolism that are associated with aberrant immune function and an elevated risk for inflammatory-associated disorders. Inflammation is a complex process, and numerous mediators affect inflammation-mediated disorders. The available clinical modalities do not effectively address the underlying diseases but rather relieve the symptoms. Therefore, novel targeted agents have the potential to normalize the metabolic system and, thus, provide meaningful therapy to the underlying disorder. In this connection, polyphenols, the well-known and extensively studied phytochemical moieties, were evaluated for their effective role in the restoration of metabolism via various mechanistic signaling pathways. The various flavonoids that we observed in this comprehensive review interfere with the metabolic events that induce inflammation. The mechanisms via which the polyphenols, in particular flavonoids, act provide a promising treatment option for inflammatory disorders. However, detailed clinical studies of such molecules are required to decide their clinical fate."]}, "AuthorList": [{"Identifier": ["0000-0001-7081-6521"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmaceutical Sciences Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah 6715847141, Iran. mh.farzaei@gmail.com."}], "LastName": "Farzaei", "ForeName": "Mohammad Hosein", "Initials": "MH"}, {"Identifier": ["0000-0002-4438-4427"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, University of Allahabad, Allahabad 211 002, India. amitfbs21@gmail.com."}], "LastName": "Singh", "ForeName": "Amit Kumar", "Initials": "AK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, University of Allahabad, Allahabad 211 002, India. rameshbiochem91@gmail.com."}], "LastName": "Kumar", "ForeName": "Ramesh", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Lake Erie College of Osteopathic Medicine, Bradenton, FL 34211, USA. CCroley48578@med.lecom.edu."}], "LastName": "Croley", "ForeName": "Courtney R", "Initials": "CR"}, {"Identifier": ["0000-0002-4774-3085"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, University of Allahabad, Allahabad 211 002, India. akpandey23@rediffmail.com."}], "LastName": "Pandey", "ForeName": "Abhay K", "Initials": "AK"}, {"Identifier": ["0000-0002-3553-9749"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Bioorganic Chemistry Laboratory, Facultad de Ciencias B\u00e1sicas y Aplicadas, Campus Nueva Granada, Universidad Militar Nueva Granada, Cajic\u00e1 250247, Colombia. Ericsson.coy@unimilitar.edu.co."}], "LastName": "Coy-Barrera", "ForeName": "Ericsson", "Initials": "E"}, {"Identifier": ["0000-0003-4118-4355"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Institute of Biotechnology and Medical Converged Science, Dongguk University-Seoul, Ilsandong-gu, Gyeonggi-do 10326, Korea. jkpatra@dongguk.edu."}], "LastName": "Kumar Patra", "ForeName": "Jayanta", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Institute of Biotechnology and Medical Converged Science, Dongguk University-Seoul, Ilsandong-gu, Gyeonggi-do 10326, Korea. gitishreedas@yahoo.co.in."}], "LastName": "Das", "ForeName": "Gitishree", "Initials": "G"}, {"Identifier": ["0000-0002-2943-3681"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Post Graduate Department of Biotechnology, Utkal University, Vani Vihar, Bhubaneswar 751 004, Odisha, India. routgeorgekerry3@gmail.com."}], "LastName": "Kerry", "ForeName": "Rout George", "Initials": "RG"}, {"Identifier": ["0000-0002-1922-662X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, University of Naples \"Federico II\", Via Domenico Montesano 49, 80131 Naples, Italy. giuseppe.annunziata@unina.it."}], "LastName": "Annunziata", "ForeName": "Giuseppe", "Initials": "G"}, {"Identifier": ["0000-0002-0251-9936"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, University of Naples \"Federico II\", Via Domenico Montesano 49, 80131 Naples, Italy. giancarlo.tenore@unina.it."}], "LastName": "Tenore", "ForeName": "Gian Carlo", "Initials": "GC"}, {"Identifier": ["0000-0002-1736-4404"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Abdul Wali Khan University, Mardan 23200, Pakistan. hkdr2006@gmail.com."}], "LastName": "Khan", "ForeName": "Haroon", "Initials": "H"}, {"Identifier": ["0000-0003-3525-1531"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy and Biotechnology, Alma Mater Studiorum-University of Bologna, 40126 Bologna, Italy. matteo.micucci2@unibo.it."}], "LastName": "Micucci", "ForeName": "Matteo", "Initials": "M"}, {"Identifier": ["0000-0002-8454-9740"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy and Biotechnology, Alma Mater Studiorum-University of Bologna, 40126 Bologna, Italy. roberta.budriesi@unibo.it."}], "LastName": "Budriesi", "ForeName": "Roberta", "Initials": "R"}, {"Identifier": ["0000-0003-3957-3300"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Plants Research Center, Institute of Medicinal Plants, Karaj 141554364, Iran. saeideh58_momtaz@yahoo.com."}, {"Identifier": [], "Affiliation": "Pharmaceutical Sciences Research Center, The Institute of Pharmaceutical Sciences, Tehran University of Medical Sciences, Tehran 141556451, Iran. saeideh58_momtaz@yahoo.com."}], "LastName": "Momtaz", "ForeName": "Saeideh", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Applied Biotechnology Research Center, Baqiyatallah University of Medical Sciences, Tehran 1435916471, Iran. Nabavi208@gmail.com."}], "LastName": "Nabavi", "ForeName": "Seyed Mohammad", "Initials": "SM"}, {"Identifier": ["0000-0001-9159-960X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Lake Erie College of Osteopathic Medicine, Bradenton, FL 34211, USA. abishayee@lecom.edu."}], "LastName": "Bishayee", "ForeName": "Anupam", "Initials": "A"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Int J Mol Sci", "NlmUniqueID": "101092791", "ISSNLinking": "1422-0067"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Inflammatory Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Biomarkers"}, {"RegistryNumber": "0", "NameOfSubstance": "Flavonoids"}, {"RegistryNumber": "0", "NameOfSubstance": "Inflammation Mediators"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["chemistry", "pharmacology", "therapeutic use"], "DescriptorName": "Anti-Inflammatory Agents"}, {"QualifierName": [], "DescriptorName": "Biomarkers"}, {"QualifierName": [], "DescriptorName": "Clinical Trials as Topic"}, {"QualifierName": [], "DescriptorName": "Disease Susceptibility"}, {"QualifierName": [], "DescriptorName": "Drug Evaluation, Preclinical"}, {"QualifierName": ["chemistry", "pharmacology", "therapeutic use"], "DescriptorName": "Flavonoids"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["complications", "diagnosis", "metabolism"], "DescriptorName": "Inflammation"}, {"QualifierName": ["metabolism"], "DescriptorName": "Inflammation Mediators"}, {"QualifierName": ["diagnosis", "drug therapy", "etiology", "metabolism"], "DescriptorName": "Metabolic Diseases"}, {"QualifierName": ["drug effects"], "DescriptorName": "Oxidative Stress"}, {"QualifierName": ["drug effects"], "DescriptorName": "Signal Transduction"}, {"QualifierName": [], "DescriptorName": "Treatment Outcome"}], "CoiStatement": "The authors declare no conflicts of interest. "}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Wellen K.E., Hotamisligil G.S. Inflammation, stress, and diabetes. J. Clin. Investig. 2005;115:1111\u20131119. doi: 10.1172/JCI25102.", "ArticleIdList": ["10.1172/JCI25102", "PMC1087185", "15864338"]}, {"Citation": "LeRoith D., Taylor S.I., Olefsky J.M. Diabetes Mellitus: A Fundamental and Clinical Text. Lippincott Williams & Wilkins; Philadelphia, PA, USA: 2004."}, {"Citation": "Hurley J.V.J.V. Acute Inflammation. Churchill Livingstone; Edinburgh, UK: 1972."}, {"Citation": "Ryan G.B., Majno G. Acute inflammation. A review. Am. J. Pathol. 1977;86:183\u2013276.", "ArticleIdList": ["PMC2032041", "64118"]}, {"Citation": "Feghali C.A., Wright T.M. Cytokines in acute and chronic inflammation. Front. Biosci. 1997;2:12\u201326.", "ArticleIdList": ["9159205"]}, {"Citation": "Balkwill F., Mantovani A. Inflammation and cancer: Back to Virchow? Lancet. 2001;357:539\u2013545. doi: 10.1016/S0140-6736(00)04046-0.", "ArticleIdList": ["10.1016/S0140-6736(00)04046-0", "11229684"]}, {"Citation": "Coussens L.M., Werb Z. Inflammation and cancer. Nature. 2002;420:860. doi: 10.1038/nature01322.", "ArticleIdList": ["10.1038/nature01322", "PMC2803035", "12490959"]}, {"Citation": "Hussain S.P., Harris C.C. Inflammation and cancer: An ancient link with novel potentials. Int. J. Cancer. 2007;121:2373\u20132380. doi: 10.1002/ijc.23173.", "ArticleIdList": ["10.1002/ijc.23173", "17893866"]}, {"Citation": "Balkwill F.R., Mantovani A. Cancer-related inflammation: Common themes and therapeutic opportunities. Semin. Cancer Biol. 2012;22:33\u201340. doi: 10.1016/j.semcancer.2011.12.005.", "ArticleIdList": ["10.1016/j.semcancer.2011.12.005", "22210179"]}, {"Citation": "Candido J., Hagemann T. Cancer-related inflammation. J. Clin. Immunol. 2013;33:S79\u2013S84. doi: 10.1007/s10875-012-9847-0.", "ArticleIdList": ["10.1007/s10875-012-9847-0", "23225204"]}, {"Citation": "Mathieu J., Tissot M., Nolibe D., Florentin I., Kergonou J.F., Giroud J.P. Local and systemic effects of an acute inflammation on eicosanoid generation capacity of polymorphonuclear cells and macrophages. Int. J. Exp. Pathol. 1990;71:603\u2013616.", "ArticleIdList": ["PMC2001975", "2169856"]}, {"Citation": "Cicchitti L., Martelli M., Cerritelli F. Chronic inflammatory disease and osteopathy: A systematic review. PLoS ONE. 2015;10:e0121327. doi: 10.1371/journal.pone.0121327.", "ArticleIdList": ["10.1371/journal.pone.0121327", "PMC4363664", "25781621"]}, {"Citation": "Hotamisligil G.S. Inflammation and metabolic disorders. Nature. 2006;444:860\u2013867. doi: 10.1038/nature05485.", "ArticleIdList": ["10.1038/nature05485", "17167474"]}, {"Citation": "Creely S.J., McTernan P.G., Kusminski C.M., Fisher f M., Da Silva N.F., Khanolkar M., Evans M., Harte A.L., Kumar S. Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am. J. Physiol. Endocrinol. Metab. 2007;292:E740\u2013E747. doi: 10.1152/ajpendo.00302.2006.", "ArticleIdList": ["10.1152/ajpendo.00302.2006", "17090751"]}, {"Citation": "Cani P.D., Bibiloni R., Knauf C., Waget A., Neyrinck A.M., Delzenne N.M., Burcelin R. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes. 2008;57:1470\u20131481. doi: 10.2337/db07-1403.", "ArticleIdList": ["10.2337/db07-1403", "18305141"]}, {"Citation": "Freigang S., Ampenberger F., Weiss A., Kanneganti T.-D., Iwakura Y., Hersberger M., Kopf M. Fatty acid\u2013induced mitochondrial uncoupling elicits inflammasome-independent IL-1\u03b1 and sterile vascular inflammation in atherosclerosis. Nat. Immunol. 2013;14:1045. doi: 10.1038/ni.2704.", "ArticleIdList": ["10.1038/ni.2704", "23995233"]}, {"Citation": "Libby P., Okamoto Y., Rocha V.Z., Folco E. Inflammation in atherosclerosis: Transition from theory to practice. Circ. J. 2010;74:213\u2013220. doi: 10.1253/circj.CJ-09-0706.", "ArticleIdList": ["10.1253/circj.CJ-09-0706", "20065609"]}, {"Citation": "Dantzer R., O\u2019Connor J.C., Freund G.G., Johnson R.W., Kelley K.W. From inflammation to sickness and depression: When the immune system subjugates the brain. Nat. Rev. Neurosci. 2008;9:46. doi: 10.1038/nrn2297.", "ArticleIdList": ["10.1038/nrn2297", "PMC2919277", "18073775"]}, {"Citation": "Naseri R., Farzaei F., Haratipour P., Nabavi S.F., Habtemariam S., Farzaei M.H., Khodarahmi R., Tewari D., Momtaz S. Anthocyanins in the Management of Metabolic Syndrome: A Pharmacological and Biopharmaceutical Review. Front. Pharm. 2018;9 doi: 10.3389/fphar.2018.01310.", "ArticleIdList": ["10.3389/fphar.2018.01310", "PMC6288909", "30564116"]}, {"Citation": "Farzaei M.H., El-Senduny F.F., Momtaz S., Parvizi F., Iranpanah A., Tewari D., Naseri R., Abdolghaffari A.H., Rezaei N. An update on dietary consideration in inflammatory bowel disease: Anthocyanins and more. Expert. Rev. Gastroenterol. Hepatol. 2018;12:1007\u20131024. doi: 10.1080/17474124.2018.1513322.", "ArticleIdList": ["10.1080/17474124.2018.1513322", "30136591"]}, {"Citation": "Farzaei M.H., Bahramsoltani R., Abdolghaffari A.H., Sodagari H.R., Esfahani S.A., Rezaei N. A mechanistic review on plant-derived natural compounds as dietary supplements for prevention of inflammatory bowel disease. Expert. Rev. Gastroenterol. Hepatol. 2016;10:745\u2013758. doi: 10.1586/17474124.2016.1145546.", "ArticleIdList": ["10.1586/17474124.2016.1145546", "26799847"]}, {"Citation": "Liu K., Pi F., Zhang H., Ji J., Xia S., Cui F., Sun J., Sun X. Metabolomics Analysis To Evaluate the Anti-Inflammatory Effects of Polyphenols: Glabridin Reversed Metabolism Change Caused by LPS in RAW 264.7 Cells. J. Agric. Food Chem. 2017;65:6070\u20136079. doi: 10.1021/acs.jafc.7b01692.", "ArticleIdList": ["10.1021/acs.jafc.7b01692", "28644019"]}, {"Citation": "Park S.H., Kang J.S., Yoon Y.D., Lee K., Kim K.J., Lee K.H., Lee C.W., Moon E.Y., Han S.B., Kim B.H. Glabridin inhibits lipopolysaccharide-induced activation of a microglial cell line, BV-2, by blocking NF-\u03baB and AP-1. Phytother. Res. 2010;24:S29\u2013S34. doi: 10.1002/ptr.2872.", "ArticleIdList": ["10.1002/ptr.2872", "19455572"]}, {"Citation": "Chandrasekaran C., Deepak H., Thiyagarajan P., Kathiresan S., Sangli G.K., Deepak M., Agarwal A. Dual inhibitory effect of Glycyrrhiza glabra (GutGard\u2122) on COX and LOX products. Phytomedicine. 2011;18:278\u2013284. doi: 10.1016/j.phymed.2010.08.001.", "ArticleIdList": ["10.1016/j.phymed.2010.08.001", "20864324"]}, {"Citation": "Simmler C., Pauli G.F., Chen S.N. Phytochemistry and biological properties of glabridin. Fitoterapia. 2013;90:160\u2013184. doi: 10.1016/j.fitote.2013.07.003.", "ArticleIdList": ["10.1016/j.fitote.2013.07.003", "PMC3795865", "23850540"]}, {"Citation": "Yehuda I., Madar Z., Leikin-Frenkel A., Tamir S. Glabridin, an isoflavan from licorice root, downregulates iNOS expression and activity under high-glucose stress and inflammation. Mol. Nutr. Food Res. 2015;59:1041\u20131052. doi: 10.1002/mnfr.201400876.", "ArticleIdList": ["10.1002/mnfr.201400876", "25737160"]}, {"Citation": "Kim J.Y., Kang J.S., Kim H.M., Ryu H.S., Kim H.S., Lee H.K., Kim Y.J., Hong J.T., Kim Y., Han S.B. Inhibition of bone marrow-derived dendritic cell maturation by glabridin. Int. Immunopharmacol. 2010;10:1185\u20131193. doi: 10.1016/j.intimp.2010.06.025.", "ArticleIdList": ["10.1016/j.intimp.2010.06.025", "20633530"]}, {"Citation": "Chang W.-T., Huang W.-C., Liou C.-J. Evaluation of the anti-inflammatory effects of phloretin and phlorizin in lipopolysaccharide-stimulated mouse macrophages. Food Chem. 2012;134:972\u2013979. doi: 10.1016/j.foodchem.2012.03.002.", "ArticleIdList": ["10.1016/j.foodchem.2012.03.002", "23107715"]}, {"Citation": "Mohamed S. Functional foods against metabolic syndrome (obesity, diabetes, hypertension and dyslipidemia) and cardiovasular disease. Trends Food Sci. Technol. 2014;35:114\u2013128. doi: 10.1016/j.tifs.2013.11.001.", "ArticleIdList": ["10.1016/j.tifs.2013.11.001"]}, {"Citation": "Chuang C.C., McIntosh M.K. Potential mechanisms by which polyphenol-rich grapes prevent obesity-mediated inflammation and metabolic diseases. Annu. Rev. Nutr. 2011;31:155\u2013176. doi: 10.1146/annurev-nutr-072610-145149.", "ArticleIdList": ["10.1146/annurev-nutr-072610-145149", "21548775"]}, {"Citation": "Basu A., Du M., Sanchez K., Leyva M.J., Betts N.M., Blevins S., Wu M., Aston C.E., Lyons T.J. Green tea minimally affects biomarkers of inflammation in obese subjects with metabolic syndrome. Nutrition. 2011;27:206\u2013213. doi: 10.1016/j.nut.2010.01.015.", "ArticleIdList": ["10.1016/j.nut.2010.01.015", "PMC2952043", "20605696"]}, {"Citation": "Panahi Y., Hosseini M.S., Khalili N., Naimi E., Majeed M., Sahebkar A. Antioxidant and anti-inflammatory effects of curcuminoid-piperine combination in subjects with metabolic syndrome: A randomized controlled trial and an updated meta-analysis. Clin. Nutr. 2015;34:1101\u20131108. doi: 10.1016/j.clnu.2014.12.019.", "ArticleIdList": ["10.1016/j.clnu.2014.12.019", "25618800"]}, {"Citation": "Peluso I., Romanelli L., Palmery M. Interactions between prebiotics, probiotics, polyunsaturated fatty acids and polyphenols: Diet or supplementation for metabolic syndrome prevention? Int. J. Food Sci. Nutr. 2014;65:259\u2013267. doi: 10.3109/09637486.2014.880670.", "ArticleIdList": ["10.3109/09637486.2014.880670", "24467635"]}, {"Citation": "Amiot M.J., Riva C., Vinet A. Effects of dietary polyphenols on metabolic syndrome features in humans: A systematic review. Obes. Rev. 2016;17:573\u2013586. doi: 10.1111/obr.12409.", "ArticleIdList": ["10.1111/obr.12409", "27079631"]}, {"Citation": "Cherniack E.P. Polyphenols: Planting the seeds of treatment for the metabolic syndrome. Nutrition. 2011;27:617\u2013623. doi: 10.1016/j.nut.2010.10.013.", "ArticleIdList": ["10.1016/j.nut.2010.10.013", "21367579"]}, {"Citation": "Jungbauer A., Medjakovic S. Anti-inflammatory properties of culinary herbs and spices that ameliorate the effects of metabolic syndrome. Maturitas. 2012;71:227\u2013239. doi: 10.1016/j.maturitas.2011.12.009.", "ArticleIdList": ["10.1016/j.maturitas.2011.12.009", "22226987"]}, {"Citation": "Medzhitov R. Origin and physiological roles of inflammation. Nature. 2008;454:428\u2013435. doi: 10.1038/nature07201.", "ArticleIdList": ["10.1038/nature07201", "18650913"]}, {"Citation": "Luo W., Morrison H., de Groh M., Waters C., DesMeules M., Jones-McLean E., Ugnat A.M., Desjardins S., Lim M., Mao Y. The burden of adult obesity in Canada. Chronic. Dis. Can. 2007;27:135\u2013144.", "ArticleIdList": ["17623559"]}, {"Citation": "Kumar S., Pandey A.K. Free radicals: Health implications and their mitigation by herbals. Br. J. Med. Med. Res. 2015;7:438\u2013457. doi: 10.9734/BJMMR/2015/16284.", "ArticleIdList": ["10.9734/BJMMR/2015/16284"]}, {"Citation": "Sharma A.K., Kumar S., Chashoo G., Saxena A.K., Pandey A.K. Cell cycle inhibitory activity of Piper longum against A549 cell line and its protective effect against metal-induced toxicity in rats. Indian J. Biochem. Biophys. 2014;51:358\u2013364.", "ArticleIdList": ["25630105"]}, {"Citation": "Makowski L., Boord J.B., Maeda K., Babaev V.R., Uysal K.T., Morgan M.A., Parker R.A., Suttles J., Fazio S., Hotamisligil G.S., et al. Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis. Nat. Med. 2001;7:699\u2013705. doi: 10.1038/89076.", "ArticleIdList": ["10.1038/89076", "PMC4027052", "11385507"]}, {"Citation": "Bouloumie A., Sengenes C., Portolan G., Galitzky J., Lafontan M. Adipocyte produces matrix metalloproteinases 2 and 9: Involvement in adipose differentiation. Diabetes. 2001;50:2080\u20132086. doi: 10.2337/diabetes.50.9.2080.", "ArticleIdList": ["10.2337/diabetes.50.9.2080", "11522674"]}, {"Citation": "Mantovani A., Sica A., Locati M. Macrophage polarization comes of age. Immunity. 2005;23:344\u2013346. doi: 10.1016/j.immuni.2005.10.001.", "ArticleIdList": ["10.1016/j.immuni.2005.10.001", "16226499"]}, {"Citation": "Laskin D.L. Macrophages and inflammatory mediators in chemical toxicity: A battle of forces. Chem. Res. Toxicol. 2009;22:1376\u20131385. doi: 10.1021/tx900086v.", "ArticleIdList": ["10.1021/tx900086v", "PMC2787782", "19645497"]}, {"Citation": "Baker R.G., Hayden M.S., Ghosh S. NF-kappaB, inflammation, and metabolic disease. Cell Metab. 2011;13:11\u201322. doi: 10.1016/j.cmet.2010.12.008.", "ArticleIdList": ["10.1016/j.cmet.2010.12.008", "PMC3040418", "21195345"]}, {"Citation": "Tenoever B.R., Ng S.L., Chua M.A., McWhirter S.M., Garcia-Sastre A., Maniatis T. Multiple functions of the IKK-related kinase IKKepsilon in interferon-mediated antiviral immunity. Science. 2007;315:1274\u20131278. doi: 10.1126/science.1136567.", "ArticleIdList": ["10.1126/science.1136567", "17332413"]}, {"Citation": "Chiang S.H., Bazuine M., Lumeng C.N., Geletka L.M., Mowers J., White N.M., Ma J.T., Zhou J., Qi N., Westcott D., et al. The protein kinase IKKepsilon regulates energy balance in obese mice. Cell. 2009;138:961\u2013975. doi: 10.1016/j.cell.2009.06.046.", "ArticleIdList": ["10.1016/j.cell.2009.06.046", "PMC2756060", "19737522"]}, {"Citation": "Weisberg S.P., Hunter D., Huber R., Lemieux J., Slaymaker S., Vaddi K., Charo I., Leibel R.L., Ferrante A.W., Jr. CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J. Clin. Investig. 2006;116:115\u2013124. doi: 10.1172/JCI24335.", "ArticleIdList": ["10.1172/JCI24335", "PMC1307559", "16341265"]}, {"Citation": "Rocha V.Z., Libby P. Obesity, inflammation, and atherosclerosis. Nat. Rev. Cardiol. 2009;6:399\u2013409. doi: 10.1038/nrcardio.2009.55.", "ArticleIdList": ["10.1038/nrcardio.2009.55", "19399028"]}, {"Citation": "Kumar S., Kumar R., Dwivedi A., Pandey A.K. In vitro antioxidant, antibacterial, and cytotoxic activity and in vivo effect of Syngonium podophyllum and Eichhornia crassipes leaf extracts on isoniazid induced oxidative stress and hepatic markers. Biomed. Res. Int. 2014;2014 doi: 10.1155/2014/459452.", "ArticleIdList": ["10.1155/2014/459452", "PMC4137625", "25162013"]}, {"Citation": "Kumar S., Pandey A.K. Chemistry and biological activities of flavonoids: An overview. Sci. World J. 2013;2013 doi: 10.1155/2013/162750.", "ArticleIdList": ["10.1155/2013/162750", "PMC3891543", "24470791"]}, {"Citation": "Furukawa S., Fujita T., Shimabukuro M., Iwaki M., Yamada Y., Nakajima Y., Nakayama O., Makishima M., Matsuda M., Shimomura I. Increased oxidative stress in obesity and its impact on metabolic syndrome. J. Clin. Investig. 2004;114:1752\u20131761. doi: 10.1172/JCI21625.", "ArticleIdList": ["10.1172/JCI21625", "PMC535065", "15599400"]}, {"Citation": "Lin Z., Kumar A., SenBanerjee S., Staniszewski K., Parmar K., Vaughan D.E., Gimbrone Jr M.A., Balasubramanian V., Garc\u00eda-Carde\u00f1a G., Jain M.K. Kruppel-like factor 2 (KLF2) regulates endothelial thrombotic function. Circ. Res. 2005;96:48\u201357. doi: 10.1161/01.RES.0000159707.05637.a1.", "ArticleIdList": ["10.1161/01.RES.0000159707.05637.a1", "15718498"]}, {"Citation": "Houstis N., Rosen E.D., Lander E.S. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature. 2006;440:944. doi: 10.1038/nature04634.", "ArticleIdList": ["10.1038/nature04634", "16612386"]}, {"Citation": "Chrysant S. A new paradigm in the treatment of the cardiovascular disease continuum: Focus on prevention. Hippokratia. 2011;15:7.", "ArticleIdList": ["PMC3093150", "21607028"]}, {"Citation": "Awan Z., Genest J. Inflammation modulation and cardiovascular disease prevention. Eur. J. Prev. Cardiol. 2014;22:719\u2013733. doi: 10.1177/2047487314529350.", "ArticleIdList": ["10.1177/2047487314529350", "24711609"]}, {"Citation": "Ruparelia N., Chai J.T., Fisher E.A., Choudhury R.P. Inflammatory processes in cardiovascular disease: A route to targeted therapies. Nat. Rev. Cardiol. 2017;14 doi: 10.1038/nrcardio.2016.185.", "ArticleIdList": ["10.1038/nrcardio.2016.185", "PMC5525550", "27905474"]}, {"Citation": "Jia H., Abtahian F., Aguirre A.D., Lee S., Chia S., Lowe H., Kato K., Yonetsu T., Vergallo R., Hu S., et al. In vivo diagnosis of plaque erosion and calcified nodule in patients with acute coronary syndrome by intravascular optical coherence tomography. J. Am. Coll. Cardiol. 2013;62:1748\u20131758. doi: 10.1016/j.jacc.2013.05.071.", "ArticleIdList": ["10.1016/j.jacc.2013.05.071", "PMC3874870", "23810884"]}, {"Citation": "Frangogiannis N.G. Regulation of the inflammatory response in cardiac repair. Circ. Res. 2012;110:159\u2013173. doi: 10.1161/CIRCRESAHA.111.243162.", "ArticleIdList": ["10.1161/CIRCRESAHA.111.243162", "PMC3690135", "22223212"]}, {"Citation": "Prondzinsky R., Unverzagt S., Lemm H., Wegener N.A., Schlitt A., Heinroth K.M., Dietz S., Buerke U., Kellner P., Loppnow H., et al. Interleukin-6, -7, -8 and -10 predict outcome in acute myocardial infarction complicated by cardiogenic shock. Clin. Res. Cardiol. 2012;101:375\u2013384. doi: 10.1007/s00392-011-0403-3.", "ArticleIdList": ["10.1007/s00392-011-0403-3", "22212516"]}, {"Citation": "Vinten-Johansen J. Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury. Cardiovasc. Res. 2004;61:481\u2013497. doi: 10.1016/j.cardiores.2003.10.011.", "ArticleIdList": ["10.1016/j.cardiores.2003.10.011", "14962479"]}, {"Citation": "Nahrendorf M., Swirski F.K., Aikawa E., Stangenberg L., Wurdinger T., Figueiredo J.L., Libby P., Weissleder R., Pittet M.J. The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J. Exp. Med. 2007;204:3037\u20133047. doi: 10.1084/jem.20070885.", "ArticleIdList": ["10.1084/jem.20070885", "PMC2118517", "18025128"]}, {"Citation": "Nourshargh S., Renshaw S.A., Imhof B.A. Reverse Migration of Neutrophils: Where, When, How, and Why? Trends Immunol. 2016;37:273\u2013286. doi: 10.1016/j.it.2016.03.006.", "ArticleIdList": ["10.1016/j.it.2016.03.006", "27055913"]}, {"Citation": "Oyama J., Blais C., Jr., Liu X., Pu M., Kobzik L., Kelly R.A., Bourcier T. Reduced myocardial ischemia-reperfusion injury in toll-like receptor 4-deficient mice. Circulation. 2004;109:784\u2013789. doi: 10.1161/01.CIR.0000112575.66565.84.", "ArticleIdList": ["10.1161/01.CIR.0000112575.66565.84", "14970116"]}, {"Citation": "Riad A., Jager S., Sobirey M., Escher F., Yaulema-Riss A., Westermann D., Karatas A., Heimesaat M.M., Bereswill S., Dragun D., et al. Toll-like receptor-4 modulates survival by induction of left ventricular remodeling after myocardial infarction in mice. J. Immunol. 2008;180:6954\u20136961. doi: 10.4049/jimmunol.180.10.6954.", "ArticleIdList": ["10.4049/jimmunol.180.10.6954", "18453617"]}, {"Citation": "Ruparelia N., Godec J., Lee R., Chai J.T., Dall\u2019Armellina E., McAndrew D., Digby J.E., Forfar J.C., Prendergast B.D., Kharbanda R.K., et al. Acute myocardial infarction activates distinct inflammation and proliferation pathways in circulating monocytes, prior to recruitment, and identified through conserved transcriptional responses in mice and humans. Eur. Heart J. 2015;36:1923\u20131934. doi: 10.1093/eurheartj/ehv195.", "ArticleIdList": ["10.1093/eurheartj/ehv195", "PMC4571177", "25982896"]}, {"Citation": "Takahashi M. NLRP3 inflammasome as a novel player in myocardial infarction. Int. Heart J. 2014;55:101\u2013105. doi: 10.1536/ihj.13-388.", "ArticleIdList": ["10.1536/ihj.13-388", "24632952"]}, {"Citation": "Distelmaier K., Adlbrecht C., Jakowitsch J., Winkler S., Dunkler D., Gerner C., Wagner O., Lang I.M., Kubicek M. Local complement activation triggers neutrophil recruitment to the site of thrombus formation in acute myocardial infarction. Thromb. Haemost. 2009;102:564\u2013572. doi: 10.1160/TH09-02-0103.", "ArticleIdList": ["10.1160/TH09-02-0103", "19718478"]}, {"Citation": "Sellak H., Franzini E., Hakim J., Pasquier C. Reactive oxygen species rapidly increase endothelial ICAM-1 ability to bind neutrophils without detectable upregulation. Blood. 1994;83:2669\u20132677.", "ArticleIdList": ["7513210"]}, {"Citation": "Libby P. Inflammation and cardiovascular disease mechanisms. Am. J. Clin. Nutr. 2006;83:456\u2013460. doi: 10.1093/ajcn/83.2.456S.", "ArticleIdList": ["10.1093/ajcn/83.2.456S", "16470012"]}, {"Citation": "Libby P., Ridker P.M., Maseri A. Inflammation and atherosclerosis. Circulation. 2002;105:1135\u20131143. doi: 10.1161/hc0902.104353.", "ArticleIdList": ["10.1161/hc0902.104353", "11877368"]}, {"Citation": "Pearson T.A., Mensah G.A., Alexander R.W., Anderson J.L., Cannon R.O., 3rd, Criqui M., Fadl Y.Y., Fortmann S.P., Hong Y., Myers G.L., et al. Markers of inflammation and cardiovascular disease: Application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003;107:499\u2013511. doi: 10.1161/01.CIR.0000052939.59093.45.", "ArticleIdList": ["10.1161/01.CIR.0000052939.59093.45", "12551878"]}, {"Citation": "Golia E., Limongelli G., Natale F., Fimiani F., Maddaloni V., Pariggiano I., Bianchi R., Crisci M., D\u2019Acierno L., Giordano R., et al. Inflammation and cardiovascular disease: From pathogenesis to therapeutic target. Curr. Atheroscler Rep. 2014;16 doi: 10.1007/s11883-014-0435-z.", "ArticleIdList": ["10.1007/s11883-014-0435-z", "25037581"]}, {"Citation": "Cybulsky M.I., Iiyama K., Li H., Zhu S., Chen M., Iiyama M., Davis V., Gutierrez-Ramos J.-C., Connelly P.W., Milstone D.S. A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. J. Clin. Investig. 2001;107:1255\u20131262. doi: 10.1172/JCI11871.", "ArticleIdList": ["10.1172/JCI11871", "PMC209298", "11375415"]}, {"Citation": "Sever P.S., Dahl\u00f6f B., Poulter N.R., Wedel H., Beevers G., Caulfield M., Collins R., Kjeldsen S.E., Kristinsson A., McInnes G.T. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial\u2014Lipid Lowering Arm (ASCOT-LLA): A multicentre randomised controlled trial. Lancet. 2003;361:1149\u20131158.", "ArticleIdList": ["12686036"]}, {"Citation": "Deshmane S.L., Kremlev S., Amini S., Sawaya B.E. Monocyte chemoattractant protein-1 (MCP-1): An overview. J. Interferon Cytokine Res. 2009;29:313\u2013326. doi: 10.1089/jir.2008.0027.", "ArticleIdList": ["10.1089/jir.2008.0027", "PMC2755091", "19441883"]}, {"Citation": "Khovidhunkit W., Kim M.S., Memon R.A., Shigenaga J.K., Moser A.H., Feingold K.R., Grunfeld C. Effects of infection and inflammation on lipid and lipoprotein metabolism: Mechanisms and consequences to the host. J. Lipid Res. 2004;45:1169\u20131196. doi: 10.1194/jlr.R300019-JLR200.", "ArticleIdList": ["10.1194/jlr.R300019-JLR200", "15102878"]}, {"Citation": "Feingold K.R., Grunfeld C. The acute phase response inhibits reverse cholesterol transport. J. Lipid Res. 2010;51:682\u2013684. doi: 10.1194/jlr.E005454.", "ArticleIdList": ["10.1194/jlr.E005454", "PMC2842157", "20071695"]}, {"Citation": "Annema W., Nijstad N., Tolle M., de Boer J.F., Buijs R.V., Heeringa P., van der Giet M., Tietge U.J. Myeloperoxidase and serum amyloid A contribute to impaired in vivo reverse cholesterol transport during the acute phase response but not group IIA secretory phospholipase A(2) J. Lipid Res. 2010;51:743\u2013754. doi: 10.1194/jlr.M000323.", "ArticleIdList": ["10.1194/jlr.M000323", "PMC2842154", "20061576"]}, {"Citation": "Ronda M.C., Dijkhorst-Oei L.T., Rutten G.E. Reasons and barriers for using a patient portal: Survey among patients with diabetes mellitus. J. Med. Internet Res. 2014;16 doi: 10.2196/jmir.3457.", "ArticleIdList": ["10.2196/jmir.3457", "PMC4260081", "25424228"]}, {"Citation": "Tabas I., Williams K.J., Boren J. Subendothelial lipoprotein retention as the initiating process in atherosclerosis: Update and therapeutic implications. Circulation. 2007;116:1832\u20131844. doi: 10.1161/CIRCULATIONAHA.106.676890.", "ArticleIdList": ["10.1161/CIRCULATIONAHA.106.676890", "17938300"]}, {"Citation": "Cybulsky M.I., Gimbrone M.A., Jr. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science. 1991;251:788\u2013791. doi: 10.1126/science.1990440.", "ArticleIdList": ["10.1126/science.1990440", "1990440"]}, {"Citation": "Shao B.Z., Han B.Z., Zeng Y.X., Su D.F., Liu C. The roles of macrophage autophagy in atherosclerosis. Acta Pharm. Sin. 2016;37:150\u2013156. doi: 10.1038/aps.2015.87.", "ArticleIdList": ["10.1038/aps.2015.87", "PMC4753375", "26750103"]}, {"Citation": "Gharavi N.M., Alva J.A., Mouillesseaux K.P., Lai C., Yeh M., Yeung W., Johnson J., Szeto W.L., Hong L., Fishbein M., et al. Role of the Jak/STAT pathway in the regulation of interleukin-8 transcription by oxidized phospholipids in vitro and in atherosclerosis in vivo. J. Biol. Chem. 2007;282:31460\u201331468. doi: 10.1074/jbc.M704267200.", "ArticleIdList": ["10.1074/jbc.M704267200", "17726017"]}, {"Citation": "Hellings W.E., Peeters W., Moll F.L., Piers S.R., van Setten J., Van der Spek P.J., de Vries J.-P.P., Seldenrijk K.A., De Bruin P.C., Vink A. Composition of carotid atherosclerotic plaque is associated with cardiovascular outcome: A prognostic study. Circulation. 2010;121:1941\u20131950. doi: 10.1161/CIRCULATIONAHA.109.887497.", "ArticleIdList": ["10.1161/CIRCULATIONAHA.109.887497", "20404256"]}, {"Citation": "Vink A., Schoneveld A.H., Lamers D., Houben A.J., van der Groep P., van Diest P.J., Pasterkamp G. HIF-1 alpha expression is associated with an atheromatous inflammatory plaque phenotype and upregulated in activated macrophages. Atherosclerosis. 2007;195:69\u201375. doi: 10.1016/j.atherosclerosis.2007.05.026.", "ArticleIdList": ["10.1016/j.atherosclerosis.2007.05.026", "17606258"]}, {"Citation": "Folco E.J., Sheikine Y., Rocha V.Z., Christen T., Shvartz E., Sukhova G.K., Di Carli M.F., Libby P. Hypoxia but not inflammation augments glucose uptake in human macrophages: Implications for imaging atherosclerosis with 18fluorine-labeled 2-deoxy-D-glucose positron emission tomography. J. Am. Coll. Cardiol. 2011;58:603\u2013614. doi: 10.1016/j.jacc.2011.03.044.", "ArticleIdList": ["10.1016/j.jacc.2011.03.044", "21798423"]}, {"Citation": "Wild S., Roglic G., Green A., Sicree R., King H. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047\u20131053. doi: 10.2337/diacare.27.5.1047.", "ArticleIdList": ["10.2337/diacare.27.5.1047", "15111519"]}, {"Citation": "Semenkovich C.F. Insulin resistance and atherosclerosis. J. Clin. Investig. 2006;116:1813\u20131822. doi: 10.1172/JCI29024.", "ArticleIdList": ["10.1172/JCI29024", "PMC1483180", "16823479"]}, {"Citation": "King A.J. The use of animal models in diabetes research. Br. J. Pharmacol. 2012;166:877\u2013894. doi: 10.1111/j.1476-5381.2012.01911.x.", "ArticleIdList": ["10.1111/j.1476-5381.2012.01911.x", "PMC3417415", "22352879"]}, {"Citation": "Singh R., Shaw J., Zimmet P. Epidemiology of childhood type 2 diabetes in the developing world. Pediatr Diabetes. 2004;5:154\u2013168. doi: 10.1111/j.1399-543X.2004.00060.x.", "ArticleIdList": ["10.1111/j.1399-543X.2004.00060.x", "15450011"]}, {"Citation": "Atkinson M.A., Eisenbarth G.S., Michels A.W. Type 1 diabetes. Lancet. 2014;383:69\u201382. doi: 10.1016/S0140-6736(13)60591-7.", "ArticleIdList": ["10.1016/S0140-6736(13)60591-7", "PMC4380133", "23890997"]}, {"Citation": "Atkinson M.A. The pathogenesis and natural history of type 1 diabetes. Cold Spring Harb. Perspect. Med. 2012;2 doi: 10.1101/cshperspect.a007641.", "ArticleIdList": ["10.1101/cshperspect.a007641", "PMC3543105", "23125199"]}, {"Citation": "Yoon J.W., Jun H.S. Autoimmune destruction of pancreatic beta cells. Am. J. 2005;12:580\u2013591.", "ArticleIdList": ["16280652"]}, {"Citation": "van Lummel M., Zaldumbide A., Roep B.O. Changing faces, unmasking the beta-cell: Post-translational modification of antigens in type 1 diabetes. Curr. Opin. Endocrinol. Diabetes Obes. 2013;20:299\u2013306. doi: 10.1097/MED.0b013e3283631417.", "ArticleIdList": ["10.1097/MED.0b013e3283631417", "23770733"]}, {"Citation": "Vcelakova J., Blatny R., Halbhuber Z., Kolar M., Neuwirth A., Petruzelkova L., Ulmannova T., Kolouskova S., Sumnik Z., Pithova P. The effect of diabetes-associated autoantigens on cell processes in human PBMCs and their relevance to autoimmune diabetes development. J. Diabetes Res. 2013;2013 doi: 10.1155/2013/589451.", "ArticleIdList": ["10.1155/2013/589451", "PMC3694381", "23841104"]}, {"Citation": "Mauvais F.X., Diana J., van Endert P. Beta cell antigens in type 1 diabetes: Triggers in pathogenesis and therapeutic targets. F1000Research. 2016;5 doi: 10.12688/f1000research.7411.1.", "ArticleIdList": ["10.12688/f1000research.7411.1", "PMC4847563", "27158463"]}, {"Citation": "Zhao Y., Krishnamurthy B., Mollah Z.U., Kay T.W., Thomas H.E. NF-kappaB in type 1 diabetes. Inflamm. Allergy Drug Targets. 2011;10:208\u2013217. doi: 10.2174/187152811795564046.", "ArticleIdList": ["10.2174/187152811795564046", "21495968"]}, {"Citation": "Limbert C. Type 1 diabetes-an auto-inflammatory disease: A new concept, new therapeutical strategies. J. Transl. Med. 2012;10:I12. doi: 10.1186/1479-5876-10-S3-I12.", "ArticleIdList": ["10.1186/1479-5876-10-S3-I12"]}, {"Citation": "Hohmeier H.E., Tran V.V., Chen G., Gasa R., Newgard C.B. Inflammatory mechanisms in diabetes: Lessons from the beta-cell. Int J. Obes Relat Metab Disord. 2003;27:12\u201316. doi: 10.1038/sj.ijo.0802493.", "ArticleIdList": ["10.1038/sj.ijo.0802493", "14704737"]}, {"Citation": "Kaneto H., Matsuoka T.A., Katakami N., Kawamori D., Miyatsuka T., Yoshiuchi K., Yasuda T., Sakamoto K., Yamasaki Y., Matsuhisa M. Oxidative stress and the JNK pathway are involved in the development of type 1 and type 2 diabetes. Curr. Mol. Med. 2007;7:674\u2013686. doi: 10.2174/156652407782564408.", "ArticleIdList": ["10.2174/156652407782564408", "18045145"]}, {"Citation": "Nishiyama T., Mae T., Kishida H., Tsukagawa M., Mimaki Y., Kuroda M., Sashida Y., Takahashi K., Kawada T., Nakagawa K., et al. Curcuminoids and sesquiterpenoids in turmeric (Curcuma longa L.) suppress an increase in blood glucose level in type 2 diabetic KK-Ay mice. J. Agric. Food Chem. 2005;53:959\u2013963. doi: 10.1021/jf0483873.", "ArticleIdList": ["10.1021/jf0483873", "15713005"]}, {"Citation": "Chawla A., Nguyen K.D., Goh Y.P. Macrophage-mediated inflammation in metabolic disease. Nat. Rev. Immunol. 2011;11:738\u2013749. doi: 10.1038/nri3071.", "ArticleIdList": ["10.1038/nri3071", "PMC3383854", "21984069"]}, {"Citation": "Mavrogiannaki A.N., Migdalis I.N. Nonalcoholic Fatty liver disease, diabetes mellitus and cardiovascular disease: Newer data. Int. J. Endocrinol. 2013;2013 doi: 10.1155/2013/450639.", "ArticleIdList": ["10.1155/2013/450639", "PMC3638654", "23653642"]}, {"Citation": "Saltiel A.R., Pessin J.E. Insulin signaling pathways in time and space. Trends Cell Biol. 2002;12:65\u201371. doi: 10.1016/S0962-8924(01)02207-3.", "ArticleIdList": ["10.1016/S0962-8924(01)02207-3", "11849969"]}, {"Citation": "Rehman K., Akash M.S. Mechanisms of inflammatory responses and development of insulin resistance: How are they interlinked? J. Biomed. Sci. 2016;23 doi: 10.1186/s12929-016-0303-y.", "ArticleIdList": ["10.1186/s12929-016-0303-y", "PMC5135788", "27912756"]}, {"Citation": "Badawi A., Klip A., Haddad P., Cole D.E., Bailo B.G., El-Sohemy A., Karmali M. Type 2 diabetes mellitus and inflammation: Prospects for biomarkers of risk and nutritional intervention. Diabetes Metab. Syndr. Obes. 2010;3:173\u2013186. doi: 10.2147/DMSO.S9089.", "ArticleIdList": ["10.2147/DMSO.S9089", "PMC3047967", "21437087"]}, {"Citation": "Serrano-Marco L., Barroso E., El Kochairi I., Palomer X., Michalik L., Wahli W., Vazquez-Carrera M. The peroxisome proliferator-activated receptor (PPAR) beta/delta agonist GW501516 inhibits IL-6-induced signal transducer and activator of transcription 3 (STAT3) activation and insulin resistance in human liver cells. Diabetologia. 2012;55:743\u2013751. doi: 10.1007/s00125-011-2401-4.", "ArticleIdList": ["10.1007/s00125-011-2401-4", "22179221"]}, {"Citation": "Lukic L., Lalic N.M., Rajkovic N., Jotic A., Lalic K., Milicic T., Seferovic J.P., Macesic M., Gajovic J.S. Hypertension in obese type 2 diabetes patients is associated with increases in insulin resistance and IL-6 cytokine levels: Potential targets for an efficient preventive intervention. Int. J. Env. Res. Public. Health. 2014;11:3586\u20133598. doi: 10.3390/ijerph110403586.", "ArticleIdList": ["10.3390/ijerph110403586", "PMC4025026", "24686488"]}, {"Citation": "Kawaguchi T., Shiba N., Takano Y., Maeda T., Sata M. Hybrid training of voluntary and electrical muscle contractions decreased fasting blood glucose and serum interleukin-6 levels in elderly people: A pilot study. Appl. Physiol. Nutr. Metab. 2011;36:276\u2013283. doi: 10.1139/h10-108.", "ArticleIdList": ["10.1139/h10-108", "21609290"]}, {"Citation": "Dou L., Zhao T., Wang L., Huang X., Jiao J., Gao D., Zhang H., Shen T., Man Y., Wang S., et al. miR-200s contribute to interleukin-6 (IL-6)-induced insulin resistance in hepatocytes. J. Biol. Chem. 2013;288:22596\u201322606. doi: 10.1074/jbc.M112.423145.", "ArticleIdList": ["10.1074/jbc.M112.423145", "PMC3829346", "23798681"]}, {"Citation": "Yin J., Hao Z., Ma Y., Liao S., Li X., Fu J., Wu Y., Shen J., Zhang P., Li X., et al. Concomitant activation of the PI3K/Akt and ERK1/2 signalling is involved in cyclic compressive force-induced IL-6 secretion in MLO-Y4 cells. Cell Biol. Int. 2014;38:591\u2013598. doi: 10.1002/cbin.10235.", "ArticleIdList": ["10.1002/cbin.10235", "24375569"]}, {"Citation": "Kumar S., Pandey A.K.  Oxidative Stress-Related MicroRNAs as Diagnostic Markers: A Newer Insight in Diagnostics. In: Maurya P.K., Chandra P., editors. Oxidative Stress: Diagnostic Methods and Applications in Medical Science. Springer; Berlin/Heidelberg, Germany: 2017.  [(accessed on 29 August 2019)]. pp. 113\u2013125. Available online:  https://link.springer.com/chapter/10.1007/978-981-10-4711-4_6.", "ArticleIdList": ["10.1007/978-981-10-4711-4_6"]}, {"Citation": "Kim T.H., Choi S.E., Ha E.S., Jung J.G., Han S.J., Kim H.J., Kim D.J., Kang Y., Lee K.W. IL-6 induction of TLR-4 gene expression via STAT3 has an effect on insulin resistance in human skeletal muscle. Acta Diabetol. 2013;50:189\u2013200. doi: 10.1007/s00592-011-0259-z.", "ArticleIdList": ["10.1007/s00592-011-0259-z", "21293887"]}, {"Citation": "Gaggini M., Morelli M., Buzzigoli E., DeFronzo R.A., Bugianesi E., Gastaldelli A. Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease. Nutrients. 2013;5:1544\u20131560. doi: 10.3390/nu5051544.", "ArticleIdList": ["10.3390/nu5051544", "PMC3708335", "23666091"]}, {"Citation": "Crook M. Type 2 diabetes mellitus: A disease of the innate immune system? An update. Diabet. Med. 2004;21:203\u2013207. doi: 10.1046/j.1464-5491.2003.01030.x.", "ArticleIdList": ["10.1046/j.1464-5491.2003.01030.x", "15008827"]}, {"Citation": "Pickup J.C. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care. 2004;27:813\u2013823. doi: 10.2337/diacare.27.3.813.", "ArticleIdList": ["10.2337/diacare.27.3.813", "14988310"]}, {"Citation": "Gregor M.F., Hotamisligil G.S. Inflammatory mechanisms in obesity. Annu. Rev. Immunol. 2011;29:415\u2013445. doi: 10.1146/annurev-immunol-031210-101322.", "ArticleIdList": ["10.1146/annurev-immunol-031210-101322", "21219177"]}, {"Citation": "Klop B., Elte J.W.F., Cabezas M.C. Dyslipidemia in obesity: Mechanisms and potential targets. Nutrients. 2013;5:1218\u20131240. doi: 10.3390/nu5041218.", "ArticleIdList": ["10.3390/nu5041218", "PMC3705344", "23584084"]}, {"Citation": "Calder P.C., Ahluwalia N., Brouns F., Buetler T., Clement K., Cunningham K., Esposito K., J\u00f6nsson L.S., Kolb H., Lansink M. Dietary factors and low-grade inflammation in relation to overweight and obesity. Br. J. Nutr. 2011;106:S71\u2013S78. doi: 10.1017/S0007114511005460.", "ArticleIdList": ["10.1017/S0007114511005460", "22133051"]}, {"Citation": "Bray G.A., Fr\u00fchbeck G., Ryan D.H., Wilding J.P.H. Management of obesity. Lancet. 2016;387:1947\u20131956. doi: 10.1016/S0140-6736(16)00271-3.", "ArticleIdList": ["10.1016/S0140-6736(16)00271-3", "26868660"]}, {"Citation": "Li Z., Hardij J., Bagchi D.P., Scheller E.L., MacDougald O.A. Development, regulation, metabolism and function of bone marrow adipose tissues. Bone. 2018;110:134\u2013140. doi: 10.1016/j.bone.2018.01.008.", "ArticleIdList": ["10.1016/j.bone.2018.01.008", "PMC6277028", "29343445"]}, {"Citation": "Onder Y., Green C.B. Rhythms of metabolism in adipose tissue and mitochondria. Neurobiol. Sleep Circadian Rhythm. 2018;4:57\u201363. doi: 10.1016/j.nbscr.2018.01.001.", "ArticleIdList": ["10.1016/j.nbscr.2018.01.001", "PMC6329595", "30637351"]}, {"Citation": "Cawthorn W.P., Sethi J.K. TNF-\u03b1 and adipocyte biology. Febs. Lett. 2008;582:117\u2013131. doi: 10.1016/j.febslet.2007.11.051.", "ArticleIdList": ["10.1016/j.febslet.2007.11.051", "PMC4304634", "18037376"]}, {"Citation": "McTernan P.G., Harte A.L., Anderson L.A., Green A., Smith S.A., Holder J.C., Barnett A.H., Eggo M.C., Kumar S. Insulin and rosiglitazone regulation of lipolysis and lipogenesis in human adipose tissue in vitro. Diabetes. 2002;51:1493\u20131498. doi: 10.2337/diabetes.51.5.1493.", "ArticleIdList": ["10.2337/diabetes.51.5.1493", "11978647"]}, {"Citation": "de Luca C., Olefsky J.M. Inflammation and insulin resistance. Febs. Lett. 2008;582:97\u2013105. doi: 10.1016/j.febslet.2007.11.057.", "ArticleIdList": ["10.1016/j.febslet.2007.11.057", "PMC2246086", "18053812"]}, {"Citation": "Chen F., Castranova V., Shi X., Demers L.M. New insights into the role of nuclear factor-\u03baB, a ubiquitous transcription factor in the initiation of diseases. Clin. Chem. 1999;45:7\u201317.", "ArticleIdList": ["9895331"]}, {"Citation": "Shirane M., Hatakeyama S., Hattori K., Nakayama K., Nakayama K.-I. Common pathway for the ubiquitination of I\u03baB\u03b1, I\u03baB\u03b2, and I\u03baB\u03b5 mediated by the F-box protein FWD1. J. Biol. Chem. 1999;274:28169\u201328174. doi: 10.1074/jbc.274.40.28169.", "ArticleIdList": ["10.1074/jbc.274.40.28169", "10497169"]}, {"Citation": "DiDonato J.A., Hayakawa M., Rothwarf D.M., Zandi E., Karin M. A cytokine-responsive I\u03baB kinase that activates the transcription factor NF-\u03baB. Nature. 1997;388:548. doi: 10.1038/41493.", "ArticleIdList": ["10.1038/41493", "9252186"]}, {"Citation": "Chen Z., Hagler J., Palombella V.J., Melandri F., Scherer D., Ballard D., Maniatis T. Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway. Genes. Dev. 1995;9:1586\u20131597. doi: 10.1101/gad.9.13.1586.", "ArticleIdList": ["10.1101/gad.9.13.1586", "7628694"]}, {"Citation": "Isra\u00ebl A. The IKK complex, a central regulator of NF-\u03baB activation. Cold Spring Harb. Perspect. Biol. 2010;2 doi: 10.1101/cshperspect.a000158.", "ArticleIdList": ["10.1101/cshperspect.a000158", "PMC2829958", "20300203"]}, {"Citation": "Stolarczyk E. Adipose tissue inflammation in obesity: A metabolic or immune response? Curr. Opin. Pharmacol. 2017;37:35\u201340. doi: 10.1016/j.coph.2017.08.006.", "ArticleIdList": ["10.1016/j.coph.2017.08.006", "28843953"]}, {"Citation": "Taleb S. Inflammation in atherosclerosis. Arch. Cardiovasc. Dis. 2016;109:708\u2013715. doi: 10.1016/j.acvd.2016.04.002.", "ArticleIdList": ["10.1016/j.acvd.2016.04.002", "27595467"]}, {"Citation": "Ye J. Mechanisms of insulin resistance in obesity. Front. Med. 2013;7:14\u201324. doi: 10.1007/s11684-013-0262-6.", "ArticleIdList": ["10.1007/s11684-013-0262-6", "PMC3936017", "23471659"]}, {"Citation": "Heymsfield S.B., Wadden T.A. Mechanisms, Pathophysiology, and Management of Obesity. N. Engl. J. Med. 2017;376:254\u2013266. doi: 10.1056/NEJMra1514009.", "ArticleIdList": ["10.1056/NEJMra1514009", "28099824"]}, {"Citation": "Benedict M., Zhang X. Non-alcoholic fatty liver disease: An expanded review. World J. Hepatol. 2017;9:715\u2013732. doi: 10.4254/wjh.v9.i16.715.", "ArticleIdList": ["10.4254/wjh.v9.i16.715", "PMC5468341", "28652891"]}, {"Citation": "Kawano Y., Cohen D.E. Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease. J. Gastroenterol. 2013;48:434\u2013441. doi: 10.1007/s00535-013-0758-5.", "ArticleIdList": ["10.1007/s00535-013-0758-5", "PMC3633701", "23397118"]}, {"Citation": "Arrigo T., Leonardi S., Cuppari C., Manti S., Lanzafame A., D\u2019Angelo G., Gitto E., Marseglia L., Salpietro C. Role of the diet as a link between oxidative stress and liver diseases. World J. Gastroenterol. 2015;21:384. doi: 10.3748/wjg.v21.i2.384.", "ArticleIdList": ["10.3748/wjg.v21.i2.384", "PMC4292270", "25593454"]}, {"Citation": "Niederreiter L., Tilg H. Cytokines and fatty liver diseases. Liver Res. 2018;2:14\u201320. doi: 10.1016/j.livres.2018.03.003.", "ArticleIdList": ["10.1016/j.livres.2018.03.003"]}, {"Citation": "Singh A.K., Bishayee A., Pandey A.K. Targeting Histone Deacetylases with Natural and Synthetic Agents: An Emerging Anticancer Strategy. Nutrients. 2018;10:731. doi: 10.3390/nu10060731.", "ArticleIdList": ["10.3390/nu10060731", "PMC6024317", "29882797"]}, {"Citation": "Kubes P., Mehal W.Z. Sterile inflammation in the liver. Gastroenterology. 2012;143:1158\u20131172. doi: 10.1053/j.gastro.2012.09.008.", "ArticleIdList": ["10.1053/j.gastro.2012.09.008", "22982943"]}, {"Citation": "Tilg H. Cytokines and liver diseases. Can. J. Gastroenterol. 2001;15:661\u2013668. doi: 10.1155/2001/746736.", "ArticleIdList": ["10.1155/2001/746736", "11694902"]}, {"Citation": "Tilg H., Moschen A.R. Inflammatory mechanisms in the regulation of insulin resistance. Mol. Med. 2008;14:222\u2013231. doi: 10.2119/2007-00119.Tilg.", "ArticleIdList": ["10.2119/2007-00119.Tilg", "PMC2215762", "18235842"]}, {"Citation": "Utzschneider K.M., Kahn S.E. Review: The role of insulin resistance in nonalcoholic fatty liver disease. J. Clin. Endocrinol. Metab. 2006;91:4753\u20134761. doi: 10.1210/jc.2006-0587.", "ArticleIdList": ["10.1210/jc.2006-0587", "16968800"]}, {"Citation": "Tilg H., Moschen A.R. Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis. Hepatology. 2010;52:1836\u20131846. doi: 10.1002/hep.24001.", "ArticleIdList": ["10.1002/hep.24001", "21038418"]}, {"Citation": "Gentile C.L., Frye M.A., Pagliassotti M.J. Fatty acids and the endoplasmic reticulum in nonalcoholic fatty liver disease. Biofactors. 2011;37:8\u201316. doi: 10.1002/biof.135.", "ArticleIdList": ["10.1002/biof.135", "PMC3080031", "21328622"]}, {"Citation": "Cerpa-Cruz S., Gonz\u00e1lez-D\u00edaz V., Mart\u00ednez-Bonilla G., Guti\u00e9rrez-Ure\u00f1a S., Rodr\u00edguez-Cort\u00e9s E. Non-Alcoholic Fatty Steatohepatitis an Inflammatory Disorder Beyond the Liver. J. Clin. Cell. Immunol. 2013;4:2. doi: 10.4172/2155-9899.1000159.", "ArticleIdList": ["10.4172/2155-9899.1000159"]}, {"Citation": "Seki E., Brenner D.A., Karin M. A liver full of JNK: Signaling in regulation of cell function and disease pathogenesis, and clinical approaches. Gastroenterology. 2012;143:307\u2013320. doi: 10.1053/j.gastro.2012.06.004.", "ArticleIdList": ["10.1053/j.gastro.2012.06.004", "PMC3523093", "22705006"]}, {"Citation": "Tarantino G., Caputi A. JNKs, insulin resistance and inflammation: A possible link between NAFLD and coronary artery disease. World J. Gastroenterol. 2011;17:3785. doi: 10.3748/wjg.v17.i33.3785.", "ArticleIdList": ["10.3748/wjg.v17.i33.3785", "PMC3181439", "21987620"]}, {"Citation": "Zeng L., Tang W.J., Yin J.J., Zhou B.J. Signal transductions and nonalcoholic fatty liver: A mini-review. Int. J. Clin. Exp. Med. 2014;7:1624\u20131631.", "ArticleIdList": ["PMC4132122", "25126158"]}, {"Citation": "McClain C.J., Cohen D.A., Dinarello C.A., Cannon J.G., Shedlofsky S.I., Kaplan A.M. Serum interleukin-1 (IL-1) activity in alcoholic hepatitis. Life Sci. 1986;39:1479\u20131485. doi: 10.1016/0024-3205(86)90554-0.", "ArticleIdList": ["10.1016/0024-3205(86)90554-0", "3490610"]}, {"Citation": "Bird G.L., Sheron N., Goka A.K., Alexander G.J., Williams R.S. Increased plasma tumor necrosis factor in severe alcoholic hepatitis. Ann. Intern. Med. 1990;112:917\u2013920. doi: 10.7326/0003-4819-112-12-917.", "ArticleIdList": ["10.7326/0003-4819-112-12-917", "2339855"]}, {"Citation": "Dominguez M., Miquel R., Colmenero J., Moreno M., Garcia-Pagan J.C., Bosch J., Arroyo V., Gines P., Caballeria J., Bataller R. Hepatic expression of CXC chemokines predicts portal hypertension and survival in patients with alcoholic hepatitis. Gastroenterology. 2009;136:1639\u20131650. doi: 10.1053/j.gastro.2009.01.056.", "ArticleIdList": ["10.1053/j.gastro.2009.01.056", "19208360"]}, {"Citation": "Spahr L., Garcia I., Bresson-Hadni S., Rubbia-Brandt L., Guler R., Olleros M., Chvatchko Y., Hadengue A. Circulating concentrations of interleukin-18, interleukin-18 binding protein, and gamma interferon in patients with alcoholic hepatitis. Liver Int. 2004;24:582\u2013587. doi: 10.1111/j.1478-3231.2004.0967.x.", "ArticleIdList": ["10.1111/j.1478-3231.2004.0967.x", "15566508"]}, {"Citation": "Lemmers A., Moreno C., Gustot T., Marechal R., Degre D., Demetter P., de Nadai P., Geerts A., Quertinmont E., Vercruysse V., et al. The interleukin-17 pathway is involved in human alcoholic liver disease. Hepatology. 2009;49:646\u2013657. doi: 10.1002/hep.22680.", "ArticleIdList": ["10.1002/hep.22680", "19177575"]}, {"Citation": "Ludwig J., Viggiano T.R., McGill D.B., Oh B.J. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo. Clin. Proc. 1980;55:434\u2013438.", "ArticleIdList": ["7382552"]}, {"Citation": "Chalasani N., Younossi Z., Lavine J.E., Diehl A.M., Brunt E.M., Cusi K., Charlton M., Sanyal A.J. The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology. 2012;55:2005\u20132023. doi: 10.1002/hep.25762.", "ArticleIdList": ["10.1002/hep.25762", "22488764"]}, {"Citation": "Del Campo J.A., Gallego P., Grande L. Role of inflammatory response in liver diseases: Therapeutic strategies. World J. Hepatol. 2018;10:1\u20137. doi: 10.4254/wjh.v10.i1.1.", "ArticleIdList": ["10.4254/wjh.v10.i1.1", "PMC5787673", "29399273"]}, {"Citation": "Brunt E.M., Wong V.W., Nobili V., Day C.P., Sookoian S., Maher J.J., Bugianesi E., Sirlin C.B., Neuschwander-Tetri B.A., Rinella M.E. Nonalcoholic fatty liver disease. Nat. Rev. Dis Primers. 2015;1 doi: 10.1038/nrdp.2015.80.", "ArticleIdList": ["10.1038/nrdp.2015.80", "27188459"]}, {"Citation": "Hassan K., Bhalla V., El Regal M.E., A-Kader H.H. Nonalcoholic fatty liver disease: A comprehensive review of a growing epidemic. World J. Gastroenterol. 2014;20:12082\u201312101. doi: 10.3748/wjg.v20.i34.12082.", "ArticleIdList": ["10.3748/wjg.v20.i34.12082", "PMC4161796", "25232245"]}, {"Citation": "Chisholm J.W., Hong J., Mills S.A., Lawn R.M. The LXR ligand T0901317 induces severe lipogenesis in the db/db diabetic mouse. J. Lipid Res. 2003;44:2039\u20132048. doi: 10.1194/jlr.M300135-JLR200.", "ArticleIdList": ["10.1194/jlr.M300135-JLR200", "12923232"]}, {"Citation": "Diehl A.M., Li Z.P., Lin H.Z., Yang S.Q. Cytokines and the pathogenesis of non-alcoholic steatohepatitis. Gut. 2005;54:303\u2013306. doi: 10.1136/gut.2003.024935.", "ArticleIdList": ["10.1136/gut.2003.024935", "PMC1774847", "15647199"]}, {"Citation": "Wree A., Eguchi A., McGeough M.D., Pena C.A., Johnson C.D., Canbay A., Hoffman H.M., Feldstein A.E. NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice. Hepatology. 2014;59:898\u2013910. doi: 10.1002/hep.26592.", "ArticleIdList": ["10.1002/hep.26592", "PMC4008151", "23813842"]}, {"Citation": "Tilg H., Diehl A.M. Cytokines in alcoholic and nonalcoholic steatohepatitis. N. Engl. J. Med. 2000;343:1467\u20131476. doi: 10.1056/NEJM200011163432007.", "ArticleIdList": ["10.1056/NEJM200011163432007", "11078773"]}, {"Citation": "Martinon F., Burns K., Tschopp J. The inflammasome: A molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol. Cell. 2002;10:417\u2013426. doi: 10.1016/S1097-2765(02)00599-3.", "ArticleIdList": ["10.1016/S1097-2765(02)00599-3", "12191486"]}, {"Citation": "Ozaki E., Campbell M., Doyle S.L. Targeting the NLRP3 inflammasome in chronic inflammatory diseases: Current perspectives. J. Inflamm. Res. 2015;8:15\u201327. doi: 10.2147/JIR.S51250.", "ArticleIdList": ["10.2147/JIR.S51250", "PMC4303395", "25653548"]}, {"Citation": "Sarasota F. Global Flavonoids Market will Reach USD 1047.63 million in 2021: Zion Market Research.  [(accessed on 29 August 2019)]; Available online:  http://www.econotimes.com/Global-FlavonoidsMarket-will-reach-USD-104763-million-in-2021-ZionMarket-Research-457514."}, {"Citation": "Manach C., Scalbert A., Morand C., Remesy C., Jimenez L. Polyphenols: Food sources and bioavailability. Am. J. Clin. Nutr. 2004;79:727\u2013747. doi: 10.1093/ajcn/79.5.727.", "ArticleIdList": ["10.1093/ajcn/79.5.727", "15113710"]}, {"Citation": "Crozier A., Burns J., Aziz A.A., Stewart A.J., Rabiasz H.S., Jenkins G.I., Edwards C.A., Lean M.E. Antioxidant flavonols from fruits, vegetables and beverages: Measurements and bioavailability. Biol. Res. 2000;33:79\u201388. doi: 10.4067/S0716-97602000000200007.", "ArticleIdList": ["10.4067/S0716-97602000000200007", "15693274"]}, {"Citation": "Serafini M., Peluso I., Raguzzini A. Flavonoids as anti-inflammatory agents. Proc. Nutr. Soc. 2010;69:273\u2013278. doi: 10.1017/S002966511000162X.", "ArticleIdList": ["10.1017/S002966511000162X", "20569521"]}, {"Citation": "Vuolo M.M., Lima V.S., Junior M.R.M.  Phenolic Compounds: Structure, Classification, and Antioxidant Power. In: Segura Campos M.R., editor. Bioactive Compounds. Elsevier; Amsterdam, The Netherlands: 2019.  [(accessed on 29 August 2019)]. pp. 33\u201350. Available online:  https://www.elsevier.com/books/bioactive-compounds/campos/978-0-12-814774-0."}, {"Citation": "Hollman P.C., Katan M.B. Dietary flavonoids: Intake, health effects and bioavailability. Food Chem. Toxicol. 1999;37:937\u2013942. doi: 10.1016/S0278-6915(99)00079-4.", "ArticleIdList": ["10.1016/S0278-6915(99)00079-4", "10541448"]}, {"Citation": "van Dam R.M., Naidoo N., Landberg R. Dietary flavonoids and the development of type 2 diabetes and cardiovascular diseases: Review of recent findings. Curr. Opin. Lipidol. 2013;24:25\u201333. doi: 10.1097/MOL.0b013e32835bcdff.", "ArticleIdList": ["10.1097/MOL.0b013e32835bcdff", "23254472"]}, {"Citation": "Davis C., Bryan J., Hodgson J., Murphy K. Definition of the Mediterranean Diet: A Literature Review. Nutrients. 2015;7:9139\u20139153. doi: 10.3390/nu7115459.", "ArticleIdList": ["10.3390/nu7115459", "PMC4663587", "26556369"]}, {"Citation": "Pham-Huy L.A., He H., Pham-Huy C. Free radicals, antioxidants in disease and health. Int. J. Biomed. Sci. 2008;4:89\u201396.", "ArticleIdList": ["PMC3614697", "23675073"]}, {"Citation": "Suen J., Thomas J., Kranz A., Vun S., Miller M. Effect of Flavonoids on Oxidative Stress and Inflammation in Adults at Risk of Cardiovascular Disease: A Systematic Review. Healthcare. 2016;4:69. doi: 10.3390/healthcare4030069.", "ArticleIdList": ["10.3390/healthcare4030069", "PMC5041070", "27649255"]}, {"Citation": "Kim H.P., Son K.H., Chang H.W., Kang S.S. Anti-inflammatory plant flavonoids and cellular action mechanisms. J. Pharmacol. Sci. 2004;96:229\u2013245. doi: 10.1254/jphs.CRJ04003X.", "ArticleIdList": ["10.1254/jphs.CRJ04003X", "15539763"]}, {"Citation": "Kimata M., Shichijo M., Miura T., Serizawa I., Inagaki N., Nagai H. Effects of luteolin, quercetin and baicalein on immunoglobulin E-mediated mediator release from human cultured mast cells. Clin. Exp. Allergy. 2000;30:501\u2013508. doi: 10.1046/j.1365-2222.2000.00768.x.", "ArticleIdList": ["10.1046/j.1365-2222.2000.00768.x", "10718847"]}, {"Citation": "Manthey J.A., Grohmann K., Montanari A., Ash K., Manthey C.L. Polymethoxylated flavones derived from citrus suppress tumor necrosis factor-alpha expression by human monocytes. J. Nat. Prod. 1999;62:441\u2013444. doi: 10.1021/np980431j.", "ArticleIdList": ["10.1021/np980431j", "10096854"]}, {"Citation": "Devi K.P., Kiruthiga P.V., Pandian S.K. Emerging Role of Flavonoids in Inhibition of NF-\u03baB-Mediated Signaling Pathway: A Review. Int. J. Biomed. Pharm. Sci. 2009;3:31\u201345."}, {"Citation": "Das H., Kumar A., Lin Z., Patino W.D., Hwang P.M., Feinberg M.W., Majumder P.K., Jain M.K. Kruppel-like factor 2 (KLF2) regulates proinflammatory activation of monocytes. Proc. Natl. Acad. Sci. USA. 2006;103:6653\u20136658. doi: 10.1073/pnas.0508235103.", "ArticleIdList": ["10.1073/pnas.0508235103", "PMC1458936", "16617118"]}, {"Citation": "Schonthaler H.B., Guinea-Viniegra J., Wagner E.F. Targeting inflammation by modulating the Jun/AP-1 pathway. Ann. Rheum. Dis. 2011;70:109\u2013112. doi: 10.1136/ard.2010.140533.", "ArticleIdList": ["10.1136/ard.2010.140533", "21339212"]}, {"Citation": "Beretz A., Cazenave J.P. The effect of flavonoids on blood-vessel wall interactions. Prog. Clin. Biol. Res. 1988;280:187\u2013200.", "ArticleIdList": ["3051026"]}, {"Citation": "Geraets L., Moonen H.J., Brauers K., Wouters E.F., Bast A., Hageman G.J. Dietary flavones and flavonoles are inhibitors of poly(ADP-ribose)polymerase-1 in pulmonary epithelial cells. J. Nutr. 2007;137:2190\u20132195. doi: 10.1093/jn/137.10.2190.", "ArticleIdList": ["10.1093/jn/137.10.2190", "17884996"]}, {"Citation": "Geraets L., Moonen H.J., Brauers K., Gottschalk R.W., Wouters E.F., Bast A., Hageman G.J. Flavone as PARP-1 inhibitor: Its effect on lipopolysaccharide induced gene-expression. Eur. J. Pharmacol. 2007;573:241\u2013248. doi: 10.1016/j.ejphar.2007.07.013.", "ArticleIdList": ["10.1016/j.ejphar.2007.07.013", "17643414"]}, {"Citation": "Nakajima H., Nagaso H., Kakui N., Ishikawa M., Hiranuma T., Hoshiko S. Critical role of the automodification of poly(ADP-ribose) polymerase-1 in nuclear factor-kappaB-dependent gene expression in primary cultured mouse glial cells. J. Biol. Chem. 2004;279:42774\u201342786. doi: 10.1074/jbc.M407923200.", "ArticleIdList": ["10.1074/jbc.M407923200", "15302869"]}, {"Citation": "Esposito D., Chen A., Grace M.H., Komarnytsky S., Lila M.A. Inhibitory effects of wild blueberry anthocyanins and other flavonoids on biomarkers of acute and chronic inflammation in vitro. J. Agric. Food Chem. 2014;62:7022\u20137028. doi: 10.1021/jf4051599.", "ArticleIdList": ["10.1021/jf4051599", "24397282"]}, {"Citation": "Mao Z., Gan C., Zhu J., Ma N., Wu L., Wang L., Wang X. Anti-atherosclerotic activities of flavonoids from the flowers of Helichrysum arenarium L. MOENCH through the pathway of anti-inflammation. Bioorg. Med. Chem. Lett. 2017;27:2812\u20132817. doi: 10.1016/j.bmcl.2017.04.076.", "ArticleIdList": ["10.1016/j.bmcl.2017.04.076", "28479197"]}, {"Citation": "Garcia-Lafuente A., Guillamon E., Villares A., Rostagno M.A., Martinez J.A. Flavonoids as anti-inflammatory agents: Implications in cancer and cardiovascular disease. Inflamm. Res. 2009;58:537\u2013552. doi: 10.1007/s00011-009-0037-3.", "ArticleIdList": ["10.1007/s00011-009-0037-3", "19381780"]}, {"Citation": "Landberg R., Sun Q., Rimm E.B., Cassidy A., Scalbert A., Mantzoros C.S., Hu F.B., van Dam R.M. Selected dietary flavonoids are associated with markers of inflammation and endothelial dysfunction in U.S. women. J. Nutr. 2011;141:618\u2013625. doi: 10.3945/jn.110.133843.", "ArticleIdList": ["10.3945/jn.110.133843", "PMC3057665", "21325476"]}, {"Citation": "Steptoe A., Gibson E.L., Vuononvirta R., Hamer M., Wardle J., Rycroft J.A., Martin J.F., Erusalimsky J.D. The effects of chronic tea intake on platelet activation and inflammation: A double-blind placebo controlled trial. Atherosclerosis. 2007;193:277\u2013282. doi: 10.1016/j.atherosclerosis.2006.08.054.", "ArticleIdList": ["10.1016/j.atherosclerosis.2006.08.054", "17010979"]}, {"Citation": "Engler M.B., Engler M.M. The emerging role of flavonoid-rich cocoa and chocolate in cardiovascular health and disease. Nutr. Rev. 2006;64:109\u2013118. doi: 10.1111/j.1753-4887.2006.tb00194.x.", "ArticleIdList": ["10.1111/j.1753-4887.2006.tb00194.x", "16572598"]}, {"Citation": "Wallace T.C. Anthocyanins in cardiovascular disease. Adv. Nutr. 2011;2:1\u20137. doi: 10.3945/an.110.000042.", "ArticleIdList": ["10.3945/an.110.000042", "PMC3042791", "22211184"]}, {"Citation": "Lotito S.B., Frei B. Dietary flavonoids attenuate tumor necrosis factor alpha-induced adhesion molecule expression in human aortic endothelial cells. Structure-function relationships and activity after first pass metabolism. J. Biol. Chem. 2006;281:37102\u201337110. doi: 10.1074/jbc.M606804200.", "ArticleIdList": ["10.1074/jbc.M606804200", "16987811"]}, {"Citation": "Kobuchi H., Roy S., Sen C.K., Nguyen H.G., Packer L. Quercetin inhibits inducible ICAM-1 expression in human endothelial cells through the JNK pathway. Am. J. Physiol. 1999;277:403\u2013411. doi: 10.1152/ajpcell.1999.277.3.C403.", "ArticleIdList": ["10.1152/ajpcell.1999.277.3.C403", "10484327"]}, {"Citation": "Sen C.K., Bagchi D. Regulation of inducible adhesion molecule expression in human endothelial cells by grape seed proanthocyanidin extract. Mol. Cell. Biochem. 2001;216:1\u20137. doi: 10.1023/A:1011053300727.", "ArticleIdList": ["10.1023/A:1011053300727", "11216853"]}, {"Citation": "Chacko B.K., Chandler R.T., Mundhekar A., Khoo N., Pruitt H.M., Kucik D.F., Parks D.A., Kevil C.G., Barnes S., Patel R.P. Revealing anti-inflammatory mechanisms of soy isoflavones by flow: Modulation of leukocyte-endothelial cell interactions. Am. J. Physiol. Heart Circ. Physiol. 2005;289:908\u2013915. doi: 10.1152/ajpheart.00781.2004.", "ArticleIdList": ["10.1152/ajpheart.00781.2004", "15805228"]}, {"Citation": "Chacko B.K., Chandler R.T., D\u2019Alessandro T.L., Mundhekar A., Khoo N.K., Botting N., Barnes S., Patel R.P. Anti-inflammatory effects of isoflavones are dependent on flow and human endothelial cell PPARgamma. J. Nutr. 2007;137:351\u2013356. doi: 10.1093/jn/137.2.351.", "ArticleIdList": ["10.1093/jn/137.2.351", "17237310"]}, {"Citation": "Droke E.A., Hager K.A., Lerner M.R., Lightfoot S.A., Stoecker B.J., Brackett D.J., Smith B.J. Soy isoflavones avert chronic inflammation-induced bone loss and vascular disease. J. Inflamm. 2007;4 doi: 10.1186/1476-9255-4-17.", "ArticleIdList": ["10.1186/1476-9255-4-17", "PMC2034375", "17825101"]}, {"Citation": "Ramiro E., Franch A., Castellote C., Perez-Cano F., Permanyer J., Izquierdo-Pulido M., Castell M. Flavonoids from Theobroma cacao down-regulate inflammatory mediators. J. Agric. Food Chem. 2005;53:8506\u20138511. doi: 10.1021/jf0511042.", "ArticleIdList": ["10.1021/jf0511042", "16248545"]}, {"Citation": "Winterbone M.S., Tribolo S., Needs P.W., Kroon P.A., Hughes D.A. Physiologically relevant metabolites of quercetin have no effect on adhesion molecule or chemokine expression in human vascular smooth muscle cells. Atherosclerosis. 2009;202:431\u2013438. doi: 10.1016/j.atherosclerosis.2008.04.040.", "ArticleIdList": ["10.1016/j.atherosclerosis.2008.04.040", "18489909"]}, {"Citation": "Panicker S.R., Sreenivas P., Babu M.S., Karunagaran D., Kartha C.C. Quercetin attenuates monocyte chemoattractant protein-1 gene expression in glucose primed aortic endothelial cells through NF-\u03baB and AP-1. Pharmacol. Res. 2010;62:328\u2013336. doi: 10.1016/j.phrs.2010.06.003.", "ArticleIdList": ["10.1016/j.phrs.2010.06.003", "20542118"]}, {"Citation": "Zhu Y., Ling W., Guo H., Song F., Ye Q., Zou T., Li D., Zhang Y., Li G., Xiao Y., et al. Anti-inflammatory effect of purified dietary anthocyanin in adults with hypercholesterolemia: A randomized controlled trial. Nutr. Metab. Cardiovasc. Dis. 2013;23:843\u2013849. doi: 10.1016/j.numecd.2012.06.005.", "ArticleIdList": ["10.1016/j.numecd.2012.06.005", "22906565"]}, {"Citation": "Risitano R., Curr\u00f2 M., Cirmi S., Ferlazzo N., Campiglia P., Caccamo D., Ientile R., Navarra M. Flavonoid fraction of Bergamot juice reduces LPS-induced inflammatory response through SIRT1-mediated NF-\u03baB inhibition in THP-1 monocytes. PLoS ONE. 2014;9:e107431. doi: 10.1371/journal.pone.0107431.", "ArticleIdList": ["10.1371/journal.pone.0107431", "PMC4178028", "25260046"]}, {"Citation": "Ku S.-K., Bae J.-S. Baicalin, baicalein and wogonin inhibits high glucose-induced vascular inflammation in vitro and in vivo. BMB Rep. 2015;48:519. doi: 10.5483/BMBRep.2015.48.9.017.", "ArticleIdList": ["10.5483/BMBRep.2015.48.9.017", "PMC4641236", "25739393"]}, {"Citation": "Hsueh T.-P., Sheen J.-M., Pang J.-H.S., Bi K.-W., Huang C.-C., Wu H.-T., Huang S.-T. The anti-atherosclerotic effect of naringin is associated with reduced expressions of cell adhesion molecules and chemokines through NF-\u03baB Pathway. Molecules. 2016;21:195. doi: 10.3390/molecules21020195.", "ArticleIdList": ["10.3390/molecules21020195", "PMC6274007", "26861272"]}, {"Citation": "Cirillo P., Conte S., Cimmino G., Pellegrino G., Ziviello F., Barra G., Sasso F.C., Borgia F., De Palma R., Trimarco B. Nobiletin inhibits oxidized-LDL mediated expression of Tissue Factor in human endothelial cells through inhibition of NF-\u03baB. Biochem. Pharmacol. 2017;128:26\u201333. doi: 10.1016/j.bcp.2016.12.016.", "ArticleIdList": ["10.1016/j.bcp.2016.12.016", "28017776"]}, {"Citation": "Bhaskar S., Sudhakaran P., Helen A. Quercetin attenuates atherosclerotic inflammation and adhesion molecule expression by modulating TLR-NF-\u03baB signaling pathway. Cell. Immunol. 2016;310:131\u2013140. doi: 10.1016/j.cellimm.2016.08.011.", "ArticleIdList": ["10.1016/j.cellimm.2016.08.011", "27585526"]}, {"Citation": "Tian H., Liu Q., Qin S., Zong C., Zhang Y., Yao S., Yang N., Guan T., Guo S. Synthesis and cardiovascular protective effects of quercetin 7-O-sialic acid. J. Cell. Mol. Med. 2017;21:107\u2013120. doi: 10.1111/jcmm.12943.", "ArticleIdList": ["10.1111/jcmm.12943", "PMC5192943", "27511707"]}, {"Citation": "Deng H.-F., Wang X.-L., Sun H., Xiao X.-Z. Puerarin inhibits expression of tissue factor induced by oxidative low-density lipoprotein through activating the PI3K/Akt/eNOS pathway and inhibiting activation of ERK1/2 and NF-\u03baB. Life Sci. 2017;191:115\u2013121. doi: 10.1016/j.lfs.2017.10.018.", "ArticleIdList": ["10.1016/j.lfs.2017.10.018", "29037842"]}, {"Citation": "Jeong Y.J., Choi Y.J., Choi J.S., Kwon H.M., Kang S.W., Bae J.Y., Lee S.S., Kang J.S., Han S.J., Kang Y.H. Attenuation of monocyte adhesion and oxidised LDL uptake in luteolin-treated human endothelial cells exposed to oxidised LDL. Br. J. Nutr. 2007;97:447\u2013457. doi: 10.1017/S0007114507657894.", "ArticleIdList": ["10.1017/S0007114507657894", "17313705"]}, {"Citation": "Chanet A., Milenkovic D., Claude S., Maier J.A., Khan M.K., Rakotomanomana N., Shinkaruk S., B\u00e9rard A.M., Bennetau-Pelissero C., Mazur A. Flavanone metabolites decrease monocyte adhesion to TNF-\u03b1-activated endothelial cells by modulating expression of atherosclerosis-related genes. Br. J. Nutr. 2013;110:587\u2013598. doi: 10.1017/S0007114512005454.", "ArticleIdList": ["10.1017/S0007114512005454", "23332102"]}, {"Citation": "De Andrade C., de S\u00e1 M.S., Toloi M.T. Effects of phytoestrogens derived from soy bean on expression of adhesion molecules on HUVEC. Climacteric. 2012;15:186\u2013194. doi: 10.3109/13697137.2011.582970.", "ArticleIdList": ["10.3109/13697137.2011.582970", "22066752"]}, {"Citation": "Lee S.M., Lee Y.J., Kim Y.C., Kim J.S., Kang D.G., Lee H.S. Vascular protective role of vitexicarpin isolated from Vitex rotundifolia in human umbilical vein endothelial cells. Inflammation. 2012;35:584\u2013593. doi: 10.1007/s10753-011-9349-x.", "ArticleIdList": ["10.1007/s10753-011-9349-x", "21614554"]}, {"Citation": "Xiao H.-B., Lu X.-Y., Liu Z.-K., Luo Z.-F. Kaempferol inhibits the production of ROS to modulate OPN\u2013\u03b1 v \u03b2 3 integrin pathway in HUVECs. J. Physiol. Biochem. 2016;72:303\u2013313. doi: 10.1007/s13105-016-0479-3.", "ArticleIdList": ["10.1007/s13105-016-0479-3", "27000882"]}, {"Citation": "Lee I.-C., Bae J.-S. Suppressive effects of pelargonidin on PolyPhosphate-mediated vascular inflammatory responses. Arch. Pharmacal. Res. 2017;40:258\u2013267. doi: 10.1007/s12272-016-0856-z.", "ArticleIdList": ["10.1007/s12272-016-0856-z", "27826751"]}, {"Citation": "Shi J., Deng H., Pan H., Xu Y., Zhang M. Epigallocatechin-3-gallate attenuates microcystin-LR induced oxidative stress and inflammation in human umbilical vein endothelial cells. Chemosphere. 2017;168:25\u201331. doi: 10.1016/j.chemosphere.2016.10.037.", "ArticleIdList": ["10.1016/j.chemosphere.2016.10.037", "27776235"]}, {"Citation": "Ming X., Ding M., Zhai B., Xiao L., Piao T., Liu M. Biochanin A inhibits lipopolysaccharide-induced inflammation in human umbilical vein endothelial cells. Life Sci. 2015;136:36\u201341. doi: 10.1016/j.lfs.2015.06.015.", "ArticleIdList": ["10.1016/j.lfs.2015.06.015", "26141992"]}, {"Citation": "Limtrakul P., Yodkeeree S., Pitchakarn P., Punfa W. Anti-inflammatory effects of proanthocyanidin-rich red rice extract via suppression of MAPK, AP-1 and NF-\u03baB pathways in Raw 264.7 macrophages. Nutr. Res. Pract. 2016;10:251\u2013258. doi: 10.4162/nrp.2016.10.3.251.", "ArticleIdList": ["10.4162/nrp.2016.10.3.251", "PMC4880723", "27247720"]}, {"Citation": "Kunworarath N., Rangkadilok N., Suriyo T., Thiantanawat A., Satayavivad J. Longan (Dimocarpus longan Lour.) inhibits lipopolysaccharide-stimulated nitric oxide production in macrophages by suppressing NF-\u03baB and AP-1 signaling pathways. J. Ethnopharmacol. 2016;179:156\u2013161. doi: 10.1016/j.jep.2015.12.044.", "ArticleIdList": ["10.1016/j.jep.2015.12.044", "26721218"]}, {"Citation": "Yi Y.-S., Cho J.Y., Kim D. Cerbera manghas methanol extract exerts anti-inflammatory activity by targeting c-Jun N-terminal kinase in the AP-1 pathway. J. Ethnopharmacol. 2016;193:387\u2013396. doi: 10.1016/j.jep.2016.08.033.", "ArticleIdList": ["10.1016/j.jep.2016.08.033", "27562319"]}, {"Citation": "Takada K., Seike T., Sasaki T., Masuda Y., Ito A., Ishii H. Nobiletin, a polymethoxyflavone in citrus fruits, reduces TAFI expression in HepG2 cells through transcriptional inhibition. Thromb. Haemost. 2013;110:1060\u20131069. doi: 10.1160/TH12-08-0597.", "ArticleIdList": ["10.1160/TH12-08-0597", "23572161"]}, {"Citation": "Lee S.G., Kim B., Yang Y., Pham T.X., Park Y.-K., Manatou J., Koo S.I., Chun O.K., Lee J.-Y. Berry anthocyanins suppress the expression and secretion of proinflammatory mediators in macrophages by inhibiting nuclear translocation of NF-\u03baB independent of NRF2-mediated mechanism. J. Nutr. Biochem. 2014;25:404\u2013411. doi: 10.1016/j.jnutbio.2013.12.001.", "ArticleIdList": ["10.1016/j.jnutbio.2013.12.001", "24565673"]}, {"Citation": "Jun M.S., Kim H.S., Kim Y.M., Kim H.J., Park E.J., Lee J.H., Lee K.R., Kim Y.S., Chang K.C. Ethanol Extract of Prunella vulgaris var. lilacina Inhibits HMGB1 Release by Induction of Heme Oxygenase-1 in LPS-activated RAW 264.7 Cells and CLP-induced Septic Mice. Phytother. Res. 2012;26:605\u2013612. doi: 10.1002/ptr.3613.", "ArticleIdList": ["10.1002/ptr.3613", "21971692"]}, {"Citation": "Lv H., Yu Z., Zheng Y., Wang L., Qin X., Cheng G., Ci X. Isovitexin exerts anti-inflammatory and anti-oxidant activities on lipopolysaccharide-induced acute lung injury by inhibiting MAPK and NF-\u03baB and activating HO-1/Nrf2 pathways. Int. J. Biol. Sci. 2016;12:72. doi: 10.7150/ijbs.13188.", "ArticleIdList": ["10.7150/ijbs.13188", "PMC4679400", "26722219"]}, {"Citation": "Song Y.S., Park C.M. Luteolin and luteolin-7-O-glucoside strengthen antioxidative potential through the modulation of Nrf2/MAPK mediated HO-1 signaling cascade in RAW 264.7 cells. Food Chem. Toxicol. 2014;65:70\u201375. doi: 10.1016/j.fct.2013.12.017.", "ArticleIdList": ["10.1016/j.fct.2013.12.017", "24361407"]}, {"Citation": "Cui X., Liu X., Feng H., Zhao S., Gao H. Grape seed proanthocyanidin extracts enhance endothelial nitric oxide synthase expression through 5\u2019-AMP activated protein kinase/Surtuin 1-Krupple like factor 2 pathway and modulate blood pressure in ouabain induced hypertensive rats. Biol. Pharm. Bull. 2012;35:2192\u20132197. doi: 10.1248/bpb.b12-00598.", "ArticleIdList": ["10.1248/bpb.b12-00598", "22987017"]}, {"Citation": "Ceriello A., Motz E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arter. Thromb. Vasc. Biol. 2004;24:816\u2013823. doi: 10.1161/01.ATV.0000122852.22604.78.", "ArticleIdList": ["10.1161/01.ATV.0000122852.22604.78", "14976002"]}, {"Citation": "Wollgast J., Anklam E. Review on polyphenols in Theobroma cacao: Changes in composition during the manufacture of chocolate and methodology for identification and quantification. Food Res. Int. 2000;33:423\u2013447. doi: 10.1016/S0963-9969(00)00068-5.", "ArticleIdList": ["10.1016/S0963-9969(00)00068-5"]}, {"Citation": "Langer S., Marshall L.J., Day A.J., Morgan M.R. Flavanols and methylxanthines in commercially available dark chocolate: A study of the correlation with nonfat cocoa solids. J. Agric. Food Chem. 2011;59:8435\u20138441. doi: 10.1021/jf201398t.", "ArticleIdList": ["10.1021/jf201398t", "21699218"]}, {"Citation": "Sarria B., Martinez-Lopez S., Sierra-Cinos J.L., Garcia-Diz L., Mateos R., Bravo L. Regular consumption of a cocoa product improves the cardiometabolic profile in healthy and moderately hypercholesterolaemic adults. Br. J. Nutr. 2014;111:122\u2013134. doi: 10.1017/S000711451300202X.", "ArticleIdList": ["10.1017/S000711451300202X", "23823716"]}, {"Citation": "G\u00f3mez-Juaristi M., Gonz\u00e1lez-Torres L., Bravo L., Vaquero M., Bastida S., S\u00e1nchez-Muniz F. Beneficial effects of chocolate on cardiovascular health. Nutr. Hosp. 2011;26:289\u2013292.", "ArticleIdList": ["21666964"]}, {"Citation": "Monagas M., Khan N., Andres-Lacueva C., Casas R., Urpi-Sarda M., Llorach R., Lamuela-Raventos R.M., Estruch R. Effect of cocoa powder on the modulation of inflammatory biomarkers in patients at high risk of cardiovascular disease. Am. J. Clin. Nutr. 2009;90:1144\u20131150. doi: 10.3945/ajcn.2009.27716.", "ArticleIdList": ["10.3945/ajcn.2009.27716", "19776136"]}, {"Citation": "Wang-Polagruto J.F., Villablanca A.C., Polagruto J.A., Lee L., Holt R.R., Schrader H.R., Ensunsa J.L., Steinberg F.M., Schmitz H.H., Keen C.L. Chronic consumption of flavanol-rich cocoa improves endothelial function and decreases vascular cell adhesion molecule in hypercholesterolemic postmenopausal women. J. Cardiovasc. Pharm. 2006;47:177\u2013186. doi: 10.1097/00005344-200606001-00013.", "ArticleIdList": ["10.1097/00005344-200606001-00013", "16794456"]}, {"Citation": "Mellor D.D., Madden L.A., Smith K.A., Kilpatrick E.S., Atkin S.L. High-polyphenol chocolate reduces endothelial dysfunction and oxidative stress during acute transient hyperglycaemia in Type 2 diabetes: A pilot randomized controlled trial. Diabet. Med. 2013;30:478\u2013483. doi: 10.1111/dme.12030.", "ArticleIdList": ["10.1111/dme.12030", "23039340"]}, {"Citation": "Hooper L., Kay C., Abdelhamid A., Kroon P.A., Cohn J.S., Rimm E.B., Cassidy A. Effects of chocolate, cocoa, and flavan-3-ols on cardiovascular health: A systematic review and meta-analysis of randomized trials. Am. J. Clin. Nutr. 2012;95:740\u2013751. doi: 10.3945/ajcn.111.023457.", "ArticleIdList": ["10.3945/ajcn.111.023457", "22301923"]}, {"Citation": "Dower J.I., Geleijnse J.M., Gijsbers L., Zock P.L., Kromhout D., Hollman P.C. Effects of the pure flavonoids epicatechin and quercetin on vascular function and cardiometabolic health: A randomized, double-blind, placebo-controlled, crossover trial. Am. J. Clin. Nutr. 2015;101:914\u2013921. doi: 10.3945/ajcn.114.098590.", "ArticleIdList": ["10.3945/ajcn.114.098590", "25934864"]}, {"Citation": "Sacanella E., Vazquez-Agell M., Mena M.P., Antunez E., Fernandez-Sola J., Nicolas J.M., Lamuela-Raventos R.M., Ros E., Estruch R. Down-regulation of adhesion molecules and other inflammatory biomarkers after moderate wine consumption in healthy women: A randomized trial. Am. J. Clin. Nutr. 2007;86:1463\u20131469. doi: 10.1093/ajcn/86.5.1463.", "ArticleIdList": ["10.1093/ajcn/86.5.1463", "17991660"]}, {"Citation": "Kalin R., Righi A., Del Rosso A., Bagchi D., Generini S., Cerinic M.M., Das D.K. Activin, a grape seed-derived proanthocyanidin extract, reduces plasma levels of oxidative stress and adhesion molecules (ICAM-1, VCAM-1 and E-selectin) in systemic sclerosis. Free Radic. Res. 2002;36:819\u2013825. doi: 10.1080/1071576021000005249.", "ArticleIdList": ["10.1080/1071576021000005249", "12420739"]}, {"Citation": "Karlsen A., Paur I., Bohn S.K., Sakhi A.K., Borge G.I., Serafini M., Erlund I., Laake P., Tonstad S., Blomhoff R. Bilberry juice modulates plasma concentration of NF-kappaB related inflammatory markers in subjects at increased risk of CVD. Eur. J. Nutr. 2010;49:345\u2013355. doi: 10.1007/s00394-010-0092-0.", "ArticleIdList": ["10.1007/s00394-010-0092-0", "20119859"]}, {"Citation": "Aaby K., Skrede G., Wrolstad R.E. Phenolic composition and antioxidant activities in flesh and achenes of strawberries (Fragaria ananassa) J. Agric. Food Chem. 2005;53:4032\u20134040. doi: 10.1021/jf048001o.", "ArticleIdList": ["10.1021/jf048001o", "15884835"]}, {"Citation": "Edirisinghe I., Banaszewski K., Cappozzo J., Sandhya K., Ellis C.L., Tadapaneni R., Kappagoda C.T., Burton-Freeman B.M. Strawberry anthocyanin and its association with postprandial inflammation and insulin. Br. J. Nutr. 2011;106:913\u2013922. doi: 10.1017/S0007114511001176.", "ArticleIdList": ["10.1017/S0007114511001176", "21736853"]}, {"Citation": "Ceriello A., Esposito K., Piconi L., Ihnat M.A., Thorpe J.E., Testa R., Boemi M., Giugliano D. Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients. Diabetes. 2008;57:1349\u20131354. doi: 10.2337/db08-0063.", "ArticleIdList": ["10.2337/db08-0063", "18299315"]}, {"Citation": "Vijayalingam S., Parthiban A., Shanmugasundaram K.R., Mohan V. Abnormal antioxidant status in impaired glucose tolerance and non-insulin-dependent diabetes mellitus. Diabet. Med. 1996;13:715\u2013719. doi: 10.1002/(SICI)1096-9136(199608)13:8<715::AID-DIA172>3.0.CO;2-Z.", "ArticleIdList": ["10.1002/(SICI)1096-9136(199608)13:8<715::AID-DIA172>3.0.CO;2-Z", "8862945"]}, {"Citation": "Bast A., Wolf G., Oberbaumer I., Walther R. Oxidative and nitrosative stress induces peroxiredoxins in pancreatic beta cells. Diabetologia. 2002;45:867\u2013876. doi: 10.1007/s00125-002-0846-1.", "ArticleIdList": ["10.1007/s00125-002-0846-1", "12107731"]}, {"Citation": "Esposito K., Nappo F., Marfella R., Giugliano G., Giugliano F., Ciotola M., Quagliaro L., Ceriello A., Giugliano D. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: Role of oxidative stress. Circulation. 2002;106:2067\u20132072. doi: 10.1161/01.CIR.0000034509.14906.AE.", "ArticleIdList": ["10.1161/01.CIR.0000034509.14906.AE", "12379575"]}, {"Citation": "Heilbronn L.K., Campbell L.V. Adipose tissue macrophages, low grade inflammation and insulin resistance in human obesity. Curr. Pharm. Des. 2008;14:1225\u20131230. doi: 10.2174/138161208784246153.", "ArticleIdList": ["10.2174/138161208784246153", "18473870"]}, {"Citation": "Matulewicz N., Karczewska-Kupczewska M. Insulin resistance and chronic inflammation. Postepy. Hig. Med. Dosw. 2016;70:1245\u20131258.", "ArticleIdList": ["28026827"]}, {"Citation": "Bonamichi B., Lee J. Unusual Suspects in the Development of Obesity-Induced Inflammation and Insulin Resistance: NK cells, iNKT cells, and ILCs. Diabetes Metab. J. 2017;41:229\u2013250. doi: 10.4093/dmj.2017.41.4.229.", "ArticleIdList": ["10.4093/dmj.2017.41.4.229", "PMC5583401", "28537058"]}, {"Citation": "Chen Z., Yu R., Xiong Y., Du F., Zhu S. A vicious circle between insulin resistance and inflammation in nonalcoholic fatty liver disease. Lipids. Health Dis. 2017;16 doi: 10.1186/s12944-017-0572-9.", "ArticleIdList": ["10.1186/s12944-017-0572-9", "PMC5644081", "29037210"]}, {"Citation": "Ricci E., Cipriani S., Chiaffarino F., Malvezzi M., Parazzini F. Effects of soy isoflavones and genistein on glucose metabolism in perimenopausal and postmenopausal non-Asian women: A meta-analysis of randomized controlled trials. Menopause. 2010;17:1080\u20131086. doi: 10.1097/gme.0b013e3181dd05a9.", "ArticleIdList": ["10.1097/gme.0b013e3181dd05a9", "20581723"]}, {"Citation": "Shrime M.G., Bauer S.R., McDonald A.C., Chowdhury N.H., Coltart C.E., Ding E.L. Flavonoid-rich cocoa consumption affects multiple cardiovascular risk factors in a meta-analysis of short-term studies. J. Nutr. 2011;141:1982\u20131988. doi: 10.3945/jn.111.145482.", "ArticleIdList": ["10.3945/jn.111.145482", "21956956"]}, {"Citation": "Curtis P.J., Sampson M., Potter J., Dhatariya K., Kroon P.A., Cassidy A. Chronic ingestion of flavan-3-ols and isoflavones improves insulin sensitivity and lipoprotein status and attenuates estimated 10-year CVD risk in medicated postmenopausal women with type 2 diabetes: A 1-year, double-blind, randomized, controlled trial. Diabetes Care. 2012;35:226\u2013232. doi: 10.2337/dc11-1443.", "ArticleIdList": ["10.2337/dc11-1443", "PMC3263874", "22250063"]}, {"Citation": "Grassi D., Necozione S., Lippi C., Croce G., Valeri L., Pasqualetti P., Desideri G., Blumberg J.B., Ferri C. Cocoa reduces blood pressure and insulin resistance and improves endothelium-dependent vasodilation in hypertensives. Hypertension. 2005;46:398\u2013405. doi: 10.1161/01.HYP.0000174990.46027.70.", "ArticleIdList": ["10.1161/01.HYP.0000174990.46027.70", "16027246"]}, {"Citation": "Grassi D., Lippi C., Necozione S., Desideri G., Ferri C. Short-term administration of dark chocolate is followed by a significant increase in insulin sensitivity and a decrease in blood pressure in healthy persons. Am. J. Clin. Nutr. 2005;81:611\u2013614. doi: 10.1093/ajcn/81.3.611.", "ArticleIdList": ["10.1093/ajcn/81.3.611", "15755830"]}, {"Citation": "Desideri G., Kwik-Uribe C., Grassi D., Necozione S., Ghiadoni L., Mastroiacovo D., Raffaele A., Ferri L., Bocale R., Lechiara M.C., et al. Benefits in cognitive function, blood pressure, and insulin resistance through cocoa flavanol consumption in elderly subjects with mild cognitive impairment: The Cocoa, Cognition, and Aging (CoCoA) study. Hypertension. 2012;60:794\u2013801. doi: 10.1161/HYPERTENSIONAHA.112.193060.", "ArticleIdList": ["10.1161/HYPERTENSIONAHA.112.193060", "22892813"]}, {"Citation": "Weseler A.R., Geraets L., Moonen H.J., Manders R.J., van Loon L.J., Pennings H.J., Wouters E.F., Bast A., Hageman G.J. Poly (ADP-ribose) polymerase-1-inhibiting flavonoids attenuate cytokine release in blood from male patients with chronic obstructive pulmonary disease or type 2 diabetes. J. Nutr. 2009;139:952\u2013957. doi: 10.3945/jn.108.102756.", "ArticleIdList": ["10.3945/jn.108.102756", "19321592"]}, {"Citation": "Hoensch H.P., Oertel R. The value of flavonoids for the human nutrition: Short review and perspectives. Clin. Nutr. Exp. 2015;3:8\u201314. doi: 10.1016/j.yclnex.2015.09.001.", "ArticleIdList": ["10.1016/j.yclnex.2015.09.001"]}, {"Citation": "Perez-Cano F.J., Castell M. Flavonoids, Inflammation and Immune System. Nutrients. 2016;8:659. doi: 10.3390/nu8100659.", "ArticleIdList": ["10.3390/nu8100659", "PMC5084045", "27775647"]}, {"Citation": "Galleano M., Calabro V., Prince P.D., Litterio M.C., Piotrkowski B., Vazquez-Prieto M.A., Miatello R.M., Oteiza P.I., Fraga C.G. Flavonoids and metabolic syndrome. Ann. N. Y. Acad. Sci. 2012;1259:87\u201394. doi: 10.1111/j.1749-6632.2012.06511.x.", "ArticleIdList": ["10.1111/j.1749-6632.2012.06511.x", "22758640"]}, {"Citation": "Blumberg J.B., Ding E.L., Dixon R., Pasinetti G.M., Villarreal F. The science of cocoa flavanols: Bioavailability, emerging evidence, and proposed mechanisms. Adv. Nutr. 2014;5:547\u2013549. doi: 10.3945/an.114.006478.", "ArticleIdList": ["10.3945/an.114.006478", "PMC4188228", "25469389"]}, {"Citation": "Bohn S.K., Croft K.D., Burrows S., Puddey I.B., Mulder T.P., Fuchs D., Woodman R.J., Hodgson J.M. Effects of black tea on body composition and metabolic outcomes related to cardiovascular disease risk: A randomized controlled trial. Food Funct. 2014;5:1613\u20131620. doi: 10.1039/C4FO00209A.", "ArticleIdList": ["10.1039/C4FO00209A", "24889137"]}, {"Citation": "Mellor D.D., Sathyapalan T., Kilpatrick E.S., Beckett S., Atkin S.L. High-cocoa polyphenol-rich chocolate improves HDL cholesterol in Type 2 diabetes patients. Diabet. Med. 2010;27:1318\u20131321. doi: 10.1111/j.1464-5491.2010.03108.x.", "ArticleIdList": ["10.1111/j.1464-5491.2010.03108.x", "20968113"]}, {"Citation": "Polagruto J.A., Wang-Polagruto J.F., Braun M.M., Lee L., Kwik-Uribe C., Keen C.L. Cocoa flavanol-enriched snack bars containing phytosterols effectively lower total and low-density lipoprotein cholesterol levels. J. Am. Diet. Assoc. 2006;106:1804\u20131813. doi: 10.1016/j.jada.2006.08.012.", "ArticleIdList": ["10.1016/j.jada.2006.08.012", "17081832"]}, {"Citation": "Gardner C.D., Newell K.A., Cherin R., Haskell W.L. The effect of soy protein with or without isoflavones relative to milk protein on plasma lipids in hypercholesterolemic postmenopausal women. Am. J. Clin. Nutr. 2001;73:728\u2013735. doi: 10.1093/ajcn/73.4.728.", "ArticleIdList": ["10.1093/ajcn/73.4.728", "11273847"]}, {"Citation": "Wilson T., Luebke J.L., Morcomb E.F., Carrell E.J., Leveranz M.C., Kobs L., Schmidt T.P., Limburg P.J., Vorsa N., Singh A.P. Glycemic responses to sweetened dried and raw cranberries in humans with type 2 diabetes. J. Food Sci. 2010;75:218\u2013223. doi: 10.1111/j.1750-3841.2010.01800.x.", "ArticleIdList": ["10.1111/j.1750-3841.2010.01800.x", "21535498"]}, {"Citation": "Hokayem M., Blond E., Vidal H., Lambert K., Meugnier E., Feillet-Coudray C., Coudray C., Pesenti S., Luyton C., Lambert-Porcheron S., et al. Grape polyphenols prevent fructose-induced oxidative stress and insulin resistance in first-degree relatives of type 2 diabetic patients. Diabetes Care. 2013;36:1454\u20131461. doi: 10.2337/dc12-1652.", "ArticleIdList": ["10.2337/dc12-1652", "PMC3661802", "23275372"]}, {"Citation": "de Bock M., Derraik J.G., Brennan C.M., Biggs J.B., Morgan P.E., Hodgkinson S.C., Hofman P.L., Cutfield W.S. Olive (Olea europaea L.) leaf polyphenols improve insulin sensitivity in middle-aged overweight men: A randomized, placebo-controlled, crossover trial. PLoS ONE. 2013;8 doi: 10.1371/journal.pone.0057622.", "ArticleIdList": ["10.1371/journal.pone.0057622", "PMC3596374", "23516412"]}, {"Citation": "Ebrahimpour Koujan S., Gargari B.P., Mobasseri M., Valizadeh H., Asghari-Jafarabadi M. Effects of Silybum marianum (L.) Gaertn. (silymarin) extract supplementation on antioxidant status and hs-CRP in patients with type 2 diabetes mellitus: A randomized, triple-blind, placebo-controlled clinical trial. Phytomedicine. 2015;22:290\u2013296. doi: 10.1016/j.phymed.2014.12.010.", "ArticleIdList": ["10.1016/j.phymed.2014.12.010", "25765835"]}, {"Citation": "Sahebkar A. Effects of quercetin supplementation on lipid profile: A systematic review and meta-analysis of randomized controlled trials. Crit. Rev. Food Sci. Nutr. 2017;57:666\u2013676. doi: 10.1080/10408398.2014.948609.", "ArticleIdList": ["10.1080/10408398.2014.948609", "25897620"]}, {"Citation": "Pfeuffer M., Auinger A., Bley U., Kraus-Stojanowic I., Laue C., Winkler P., Rufer C.E., Frank J., Bosch-Saadatmandi C., Rimbach G., et al. Effect of quercetin on traits of the metabolic syndrome, endothelial function and inflammation in men with different APOE isoforms. Nutr. Metab. Cardiovasc. Dis. 2013;23:403\u2013409. doi: 10.1016/j.numecd.2011.08.010.", "ArticleIdList": ["10.1016/j.numecd.2011.08.010", "22118955"]}, {"Citation": "Dower J.I., Geleijnse J.M., Gijsbers L., Schalkwijk C., Kromhout D., Hollman P.C. Supplementation of the Pure Flavonoids Epicatechin and Quercetin Affects Some Biomarkers of Endothelial Dysfunction and Inflammation in (Pre)Hypertensive Adults: A Randomized Double-Blind, Placebo-Controlled, Crossover Trial. J. Nutr. 2015;145:1459\u20131463. doi: 10.3945/jn.115.211888.", "ArticleIdList": ["10.3945/jn.115.211888", "25972527"]}, {"Citation": "Boots A.W., Drent M., de Boer V.C., Bast A., Haenen G.R. Quercetin reduces markers of oxidative stress and inflammation in sarcoidosis. Clin. Nutr. 2011;30:506\u2013512. doi: 10.1016/j.clnu.2011.01.010.", "ArticleIdList": ["10.1016/j.clnu.2011.01.010", "21324570"]}, {"Citation": "Brull V., Burak C., Stoffel-Wagner B., Wolffram S., Nickenig G., Muller C., Langguth P., Alteheld B., Fimmers R., Stehle P., et al. No effects of quercetin from onion skin extract on serum leptin and adiponectin concentrations in overweight-to-obese patients with (pre-)hypertension: A randomized double-blinded, placebo-controlled crossover trial. Eur. J. Nutr. 2017;56:2265\u20132275. doi: 10.1007/s00394-016-1267-0.", "ArticleIdList": ["10.1007/s00394-016-1267-0", "27423432"]}, {"Citation": "Guo Y., Mah E., Davis C.G., Jalili T., Ferruzzi M.G., Chun O.K., Bruno R.S. Dietary fat increases quercetin bioavailability in overweight adults. Mol. Nutr. Food Res. 2013;57:896\u2013905. doi: 10.1002/mnfr.201200619.", "ArticleIdList": ["10.1002/mnfr.201200619", "23319447"]}, {"Citation": "Heinz S.A., Henson D.A., Nieman D.C., Austin M.D., Jin F. A 12-week supplementation with quercetin does not affect natural killer cell activity, granulocyte oxidative burst activity or granulocyte phagocytosis in female human subjects. Br. J. Nutr. 2010;104:849\u2013857. doi: 10.1017/S000711451000156X.", "ArticleIdList": ["10.1017/S000711451000156X", "20500927"]}, {"Citation": "Egert S., Boesch-Saadatmandi C., Wolffram S., Rimbach G., Muller M.J. Serum lipid and blood pressure responses to quercetin vary in overweight patients by apolipoprotein E genotype. J. Nutr. 2010;140:278\u2013284. doi: 10.3945/jn.109.117655.", "ArticleIdList": ["10.3945/jn.109.117655", "20032478"]}, {"Citation": "Javadi F., Ahmadzadeh A., Eghtesadi S., Aryaeian N., Zabihiyeganeh M., Rahimi Foroushani A., Jazayeri S. The Effect of Quercetin on Inflammatory Factors and Clinical Symptoms in Women with Rheumatoid Arthritis: A Double-Blind, Randomized Controlled Trial. J. Am. Coll. Nutr. 2017;36:9\u201315. doi: 10.1080/07315724.2016.1140093.", "ArticleIdList": ["10.1080/07315724.2016.1140093", "27710596"]}, {"Citation": "Talirevic E., Jelena S. Quercetin in the treatment of dyslipidemia. Med. Arch. 2012;66:87\u201388. doi: 10.5455/medarh.2012.66.87-88.", "ArticleIdList": ["10.5455/medarh.2012.66.87-88", "22486135"]}, {"Citation": "Gutierrez-Salmean G., Meaney E., Lanaspa M.A., Cicerchi C., Johnson R.J., Dugar S., Taub P., Ramirez-Sanchez I., Villarreal F., Schreiner G., et al. A randomized, placebo-controlled, double-blind study on the effects of (-)-epicatechin on the triglyceride/HDLc ratio and cardiometabolic profile of subjects with hypertriglyceridemia: Unique in vitro effects. Int. J. Cardiol. 2016;223:500\u2013506. doi: 10.1016/j.ijcard.2016.08.158.", "ArticleIdList": ["10.1016/j.ijcard.2016.08.158", "27552564"]}, {"Citation": "Homayouni F., Haidari F., Hedayati M., Zakerkish M., Ahmadi K. Hesperidin Supplementation Alleviates Oxidative DNA Damage and Lipid Peroxidation in Type 2 Diabetes: A Randomized Double-Blind Placebo-Controlled Clinical Trial. Phytother. Res. 2017;31:1539\u20131545. doi: 10.1002/ptr.5881.", "ArticleIdList": ["10.1002/ptr.5881", "28805022"]}, {"Citation": "Jung U.J., Kim H.J., Lee J.S., Lee M.K., Kim H.O., Park E.J., Kim H.K., Jeong T.S., Choi M.S. Naringin supplementation lowers plasma lipids and enhances erythrocyte antioxidant enzyme activities in hypercholesterolemic subjects. Clin. Nutr. 2003;22:561\u2013568. doi: 10.1016/S0261-5614(03)00059-1.", "ArticleIdList": ["10.1016/S0261-5614(03)00059-1", "14613759"]}, {"Citation": "Squadrito F., Marini H., Bitto A., Altavilla D., Polito F., Adamo E.B., D\u2019Anna R., Arcoraci V., Burnett B.P., Minutoli L., et al. Genistein in the metabolic syndrome: Results of a randomized clinical trial. J. Clin. Endocrinol. Metab. 2013;98:3366\u20133374. doi: 10.1210/jc.2013-1180.", "ArticleIdList": ["10.1210/jc.2013-1180", "23824420"]}, {"Citation": "Xiao L.Z., Huang Z., Ma S.C., Zen Z., Luo B., Lin X., Xu X. [Study on the effect and mechanism of puerarin on the size of infarction in patients with acute myocardial infarction] Zhongguo Zhong Xi Yi Jie He Za Zhi. 2004;24:790\u2013792.", "ArticleIdList": ["15495821"]}, {"Citation": "Shi W.G., Qu L., Wang J.W. [Study on interventing effect of puerarin on insulin resistance in patients with coronary heart disease] Zhongguo Zhong Xi Yi Jie He Za Zhi. 2002;22:21\u201324.", "ArticleIdList": ["12585165"]}, {"Citation": "Villa P., Costantini B., Suriano R., Perri C., Macri F., Ricciardi L., Panunzi S., Lanzone A. The differential effect of the phytoestrogen genistein on cardiovascular risk factors in postmenopausal women: Relationship with the metabolic status. J. Clin. Endocrinol. Metab. 2009;94:552\u2013558. doi: 10.1210/jc.2008-0735.", "ArticleIdList": ["10.1210/jc.2008-0735", "19017760"]}, {"Citation": "Marini H., Bitto A., Altavilla D., Burnett B.P., Polito F., Di Stefano V., Minutoli L., Atteritano M., Levy R.M., Frisina N., et al. Efficacy of genistein aglycone on some cardiovascular risk factors and homocysteine levels: A follow-up study. Nutr. Metab. Cardiovasc. Dis. 2010;20:332\u2013340. doi: 10.1016/j.numecd.2009.04.012.", "ArticleIdList": ["10.1016/j.numecd.2009.04.012", "19631515"]}, {"Citation": "de Ruijter J., Valstar M.J., Narajczyk M., Wegrzyn G., Kulik W., Ijlst L., Wagemans T., van der Wal W.M., Wijburg F.A. Genistein in Sanfilippo disease: A randomized controlled crossover trial. Ann. Neurol. 2012;71:110\u2013120. doi: 10.1002/ana.22643.", "ArticleIdList": ["10.1002/ana.22643", "22275257"]}, {"Citation": "Egert S., Bosy-Westphal A., Seiberl J., Kurbitz C., Settler U., Plachta-Danielzik S., Wagner A.E., Frank J., Schrezenmeir J., Rimbach G., et al. Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: A double-blinded, placebo-controlled cross-over study. Br. J. Nutr. 2009;102:1065\u20131074. doi: 10.1017/S0007114509359127.", "ArticleIdList": ["10.1017/S0007114509359127", "19402938"]}, {"Citation": "Shi Y., Williamson G. Quercetin lowers plasma uric acid in pre-hyperuricaemic males: A randomised, double-blinded, placebo-controlled, cross-over trial. Br. J. Nutr. 2016;115:800\u2013806. doi: 10.1017/S0007114515005310.", "ArticleIdList": ["10.1017/S0007114515005310", "26785820"]}, {"Citation": "Mielgo-Ayuso J., Barrenechea L., Alcorta P., Larrarte E., Margareto J., Labayen I. Effects of dietary supplementation with epigallocatechin-3-gallate on weight loss, energy homeostasis, cardiometabolic risk factors and liver function in obese women: Randomised, double-blind, placebo-controlled clinical trial. Br. J. Nutr. 2014;111:1263\u20131271. doi: 10.1017/S0007114513003784.", "ArticleIdList": ["10.1017/S0007114513003784", "24299662"]}, {"Citation": "Brown A.L., Lane J., Coverly J., Stocks J., Jackson S., Stephen A., Bluck L., Coward A., Hendrickx H. Effects of dietary supplementation with the green tea polyphenol epigallocatechin-3-gallate on insulin resistance and associated metabolic risk factors: Randomized controlled trial. Br. J. Nutr. 2009;101:886\u2013894. doi: 10.1017/S0007114508047727.", "ArticleIdList": ["10.1017/S0007114508047727", "PMC2819662", "18710606"]}, {"Citation": "Boschmann M., Thielecke F. The effects of epigallocatechin-3-gallate on thermogenesis and fat oxidation in obese men: A pilot study. J. Am. Coll. Nutr. 2007;26:389\u2013395. doi: 10.1080/07315724.2007.10719627.", "ArticleIdList": ["10.1080/07315724.2007.10719627", "17906192"]}, {"Citation": "Meshitsuka S., Shingaki S., Hotta M., Goto M., Kobayashi M., Ukawa Y., Sagesaka Y.M., Wada Y., Nojima M., Suzuki K. Phase 2 trial of daily, oral epigallocatechin gallate in patients with light-chain amyloidosis. Int. J. Hematol. 2017;105:295\u2013308. doi: 10.1007/s12185-016-2112-1.", "ArticleIdList": ["10.1007/s12185-016-2112-1", "27815860"]}, {"Citation": "Most J., Timmers S., Warnke I., Jocken J.W., van Boekschoten M., de Groot P., Bendik I., Schrauwen P., Goossens G.H., Blaak E.E. Combined epigallocatechin-3-gallate and resveratrol supplementation for 12 wk increases mitochondrial capacity and fat oxidation, but not insulin sensitivity, in obese humans: A randomized controlled trial. Am. J. Clin. Nutr. 2016;104:215\u2013227. doi: 10.3945/ajcn.115.122937.", "ArticleIdList": ["10.3945/ajcn.115.122937", "27194304"]}, {"Citation": "Haidari F., Heybar H., Jalali M.T., Ahmadi Engali K., Helli B., Shirbeigi E. Hesperidin supplementation modulates inflammatory responses following myocardial infarction. J. Am. Coll. Nutr. 2015;34:205\u2013211. doi: 10.1080/07315724.2014.891269.", "ArticleIdList": ["10.1080/07315724.2014.891269", "25757593"]}, {"Citation": "Demonty I., Lin Y., Zebregs Y.E., Vermeer M.A., van der Knaap H.C., Jakel M., Trautwein E.A. The citrus flavonoids hesperidin and naringin do not affect serum cholesterol in moderately hypercholesterolemic men and women. J. Nutr. 2010;140:1615\u20131620. doi: 10.3945/jn.110.124735.", "ArticleIdList": ["10.3945/jn.110.124735", "20660284"]}, {"Citation": "Rizza S., Muniyappa R., Iantorno M., Kim J.A., Chen H., Pullikotil P., Senese N., Tesauro M., Lauro D., Cardillo C., et al. Citrus polyphenol hesperidin stimulates production of nitric oxide in endothelial cells while improving endothelial function and reducing inflammatory markers in patients with metabolic syndrome. J. Clin. Endocrinol. Metab. 2011;96:782\u2013792. doi: 10.1210/jc.2010-2879.", "ArticleIdList": ["10.1210/jc.2010-2879", "PMC3085197", "21346065"]}, {"Citation": "Delgadillo V., O\u2019Callaghan Mdel M., Artuch R., Montero R., Pineda M. Genistein supplementation in patients affected by Sanfilippo disease. J. Inherit. Metab. Dis. 2011;34:1039\u20131044. doi: 10.1007/s10545-011-9342-4.", "ArticleIdList": ["10.1007/s10545-011-9342-4", "21556833"]}]}], "History": [{"Year": "2019", "Month": "8", "Day": "29"}, {"Year": "2019", "Month": "9", "Day": "28"}, {"Year": "2019", "Month": "9", "Day": "30"}, {"Year": "2019", "Month": "10", "Day": "11", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "10", "Day": "11", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "2", "Day": "18", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "10", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["31597283", "PMC6801776", "10.3390/ijms20194957", "ijms20194957"]}}]}